<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>00095 Mid Day Module (Obg-1) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Mid Day Module
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 13310,
    "choices": [
      {
        "id": 53201,
        "text": "<p><span style=\"font-size:12.0pt;\">Oral antihypertensive therapy</span></p>"
      },
      {
        "id": 53202,
        "text": "<p><span style=\"font-size:12.0pt;\">Platelet transfusion</span></p>"
      },
      {
        "id": 53203,
        "text": "<p><span style=\"font-size:12.0pt;\">Magnesium sulphate therapy and induction of labour</span></p>"
      },
      {
        "id": 53204,
        "text": "<p><span style=\"font-size:12.0pt;\">Intravenous immunoglobulin therapy</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 30-year-old primigravida woman presents at 29 weeks gestation with headache and a blood pressure of 160/110 mm Hg. Investigations reveal 2+ proteinuria on dipstick, an elevated SGOT and SGPT and a platelet count of 80,000/mm<sup>3</sup>. What is the best management?</span></p>",
    "unique_key": "Q2471162",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439041,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Magnesium sulphate therapy and induction of labour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Even if hemolysis is not established, thrombocytopenia and elevated liver enzymes point toward severe features in pre eclampsia, which needs to be treated with Magnesium sulphate therapy and induction of labour&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">HELLP syndrome is a complication of pre-eclampsia and includes</span><ul><li><span style=\"font-size:16px;\">Hemolysis</span></li><li><span style=\"font-size:16px;\">Elevated liver enzymes</span></li><li><span style=\"font-size:16px;\">Thromobocytopenia</span></li></ul></li><li><span style=\"font-size:16px;\">HELLP is an indication for termination of pregnancy.</span></li><li><span style=\"font-size:16px;\">MgSO4 also needs to be given for both seizure prophylaxis and will also provide neuro-protection of the neonate f/b delivery of the patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Severe features in pre eclampsia need to be started on magnesium sulphate therapy</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tuh4X1U.png\" width=\"1149\" height=\"607\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-134609.jpg\" alt=\"\" width=\"700\" height=\"926\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Contraindications to Conservative management in severe preeclampsia (This means deliver asap in the following scenarios):</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Remember by the mnemonic <strong>DELIVER Asap</strong></span></p><p><span style=\"font-size:16px;\">D: Fetal Distress</span></p><p><span style=\"font-size:16px;\">E: Eclampsia</span></p><p><span style=\"font-size:16px;\">L: HELLP</span></p><p><span style=\"font-size:16px;\">I: DIC</span></p><p><span style=\"font-size:16px;\">V: non-viable fetus (extremely preterm)</span></p><p><span style=\"font-size:16px;\">E: pulmonary Edema</span></p><p><span style=\"font-size:16px;\">R: Renal failure</span></p><p><span style=\"font-size:16px;\">Asap: Abruption</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Let's analyse each management option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Oral Antihypertensive Therapy: While</strong> managing high blood pressure is crucial in preeclampsia, this option alone does not address the other severe features of the condition like proteinuria, liver dysfunction, and thrombocytopenia.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Platelet Transfusion: In</strong> the context of preeclampsia, platelet transfusion is not typically a primary management strategy unless there's a risk of severe bleeding or if surgery (like cesarean section) is planned and the platelet count is critically low.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Magnesium Sulphate Therapy and Induction of Labour:</strong> This is the correct option. Given the severity of symptoms and the potential risks to both the mother and the fetus, management often involves delivery (the definitive treatment for preeclampsia), along with magnesium sulphate to prevent eclamptic seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Intravenous Immunoglobulin Therapy</strong>: IVIG is not a treatment for preeclampsia and does not address the immediate risks associated with this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In cases with severe features, like significant hypertension, proteinuria, liver dysfunction, and thrombocytopenia, the primary management is to stabilize the mother and expedite delivery, as the condition typically resolves only after delivery. Magnesium sulphate is essential for seizure prophylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Page no 1852, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53203,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13311,
    "choices": [
      {
        "id": 53205,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Deep tendon reflexes, urine output, Respiratory rate</span></span></span></p>"
      },
      {
        "id": 53206,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Deep tendon reflexes, O2 saturation, consciousness status</span></span></span></p>"
      },
      {
        "id": 53207,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">O2 saturation, urine output, heart rate</span></span></span></p>"
      },
      {
        "id": 53208,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heart rate, BP, respiratory rate&nbsp;and urine output</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 20-year primi presented at 32 weeks with eclampsia. She was started on MgSO4 (Pritchard&rsquo;s regime) and she delivered after induction of labor. Maintenance dose of MgSO4 was continued for 24 hours. Prevention of Mg toxicity involves monitoring of the following clinical parameters: </span></span></span></p>",
    "unique_key": "Q6804477",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439042,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Deep tendon reflexes, urine output, Respiratory rate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A woman on MgSO4 for management of eclampsia requires the following to be checked for Mg toxicity:</span></span></span>\r\n\r\n\t<ol>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Deep tendon reflexes</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Respiratory Rate</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urine Output</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Magnesium toxicity</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">At &gt; 7-10 mEq/L: Loss of DTR</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">10 - 12 mEq/L: Respiratory depression</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">25 mEq/L: Cardiac arrest</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Antidote: Ca gluconate (1 g IV)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The prevention of magnesium toxicity in the management of eclampsia involves careful monitoring of deep tendon reflexes, urine output, and respiratory rate. Deep tendon reflexes help detect early signs of toxicity, urine output indicates renal function and magnesium clearance, and respiratory rate assesses potential respiratory depression from magnesium sulfate. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1<sup>st</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 53205,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13312,
    "choices": [
      {
        "id": 53209,
        "text": "<p><span style=\"font-size:12.0pt;\">Emergency Cesarean section.</span></p>"
      },
      {
        "id": 53210,
        "text": "<p><span style=\"font-size:12.0pt;\">Induction of labor</span></p>"
      },
      {
        "id": 53211,
        "text": "<p><span style=\"font-size:12.0pt;\">Prophylactic MgSO4</span></p>"
      },
      {
        "id": 53212,
        "text": "<p><span style=\"font-size:12.0pt;\">Urgent Ultrasound to see the fetal status</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 22-year Primigravida presents at 34 weeks to the emergency with a BP of 160/110 mmHg. Her urine albumin is 3 +. She is complaining of headache and blurring of vision. On examination, the fetal heart cannot be auscultated. The uterus is relaxed, and a vaginal examination reveals a soft cervix which is 1 cm dilated and 30% effaced. You administer IV labetalol to lower her BP. What is the best immediate next line of management?</span></p>",
    "unique_key": "Q7487843",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439043,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Prophylactic MgSO4</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This is a patient with severe preeclampsia with imminent eclampsia with intra-uterine fetal demise</span></li><li><span style=\"font-size:12.0pt;\"><strong>She needs to be delivered but before that, the next best step would be to prevent eclampsia as she is having imminent signs (headache, blurring of vision)</strong></span></li><li><span style=\"font-size:12.0pt;\">Management of Preeclampsia:</span></li><li><span style=\"font-size:12.0pt;\">Definitive treatment is delivery</span></li><li><span style=\"font-size:12.0pt;\">Mild preeclampsia: Termination at 37 weeks</span></li><li><span style=\"font-size:12.0pt;\">Severe preeclampsia</span><ul><li><span style=\"font-size:12.0pt;\">Admit; Consider prophylactic MgSO4</span></li><li><span style=\"font-size:12.0pt;\">Start anti-hypertensives</span></li><li><span style=\"font-size:12.0pt;\">Terminate at 37 weeks or SOS if</span><ul><li><span style=\"font-size:12.0pt;\">Persistent severe HTN&nbsp;</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Eclampsia, HELLP, pulmonary edema, ARF, DIC</span></li><li><span style=\"font-size:12.0pt;\">Fetal compromise&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Abruption</span></li><li><span style=\"font-size:12.0pt;\">Pre-viable fetus</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Steroids (Betamethasone 12 mg 2 doses 24 h apart IM) for lung maturity if &lt; 34 weeks</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is a patient with severe pre-eclampsia with imminent signs of eclampsia (since she has headache and blurring of vision)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The next best step would thus be prophylactic MgSO4 followed by Induction of Labor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Let's analyse the options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Emergency Cesarean Section</strong>: In cases of viable and distressed fetuses, an emergency Cesarean section could be a consideration. However, the indication for an emergency C-section in this scenario is unclear without confirmation of the current fetal status.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Induction of Labor:</strong> Induction of labor is generally considered when the fetus is viable and the condition of the mother or fetus necessitates delivery. In this scenario, the status of the fetus is not confirmed, and induction might not be the immediate next step without further assessment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Prophylactic MgSO4</strong>: This is the correct answer. Given the signs of severe preeclampsia (high BP, proteinuria, headache, and vision changes), administering magnesium sulphate (MgSO4) is crucial for seizure prophylaxis (to prevent eclampsia). This step is important regardless of the fetal status.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urgent Ultrasound to See the Fetal Status</strong>: While an ultrasound is important to assess fetal status, especially since the fetal heart sounds are not audible, the immediate management of severe preeclampsia takes precedence to prevent maternal complications like eclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Management of Preeclampsia:</span></li><li><span style=\"font-size:12.0pt;\">Definitive treatment is delivery</span></li><li><span style=\"font-size:12.0pt;\">Mild preeclampsia: Termination at 37 weeks</span></li><li><span style=\"font-size:12.0pt;\">Severe preeclampsia</span><ul><li><span style=\"font-size:12.0pt;\">Admit; Consider prophylactic MgSO4</span></li><li><span style=\"font-size:12.0pt;\">Start anti-hypertensives</span></li><li><span style=\"font-size:12.0pt;\">Terminate at 37 weeks or SOS if</span><ul><li><span style=\"font-size:12.0pt;\">Persistent severe HTN&nbsp;</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Eclampsia, HELLP, pulmonary edema, ARF, DIC</span></li><li><span style=\"font-size:12.0pt;\">Fetal compromise&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Abruption</span></li><li><span style=\"font-size:12.0pt;\">Pre-viable fetus</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Steroids (Betamethasone 12 mg 2 doses 24 h apart IM) for lung maturity if &lt; 34 weeks</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 732, Williams Obstetrics 25<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53211,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13313,
    "choices": [
      {
        "id": 53213,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neuroprotection in preterm labor</span></span></span></p>"
      },
      {
        "id": 53214,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe preeclampsia</span></span></span></p>"
      },
      {
        "id": 53215,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tocolysis</span></span></span></p>"
      },
      {
        "id": 53216,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe IUGR</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is NOT an indication of using this drug in obstetrics?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/picture1.jpg\" style=\"height:294px; width:500px\" /></span></span></span></span></p>",
    "unique_key": "Q1673546",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439044,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. Severe IUGR</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MgSO4 is used for the following obstetric indications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eclampsia &amp; severe preeclampsia </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As a tocolytic in preterm labor</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For neuroprotection in very preterm</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Let&#39;s review each option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Neuroprotection in Preterm Labor:</span></strong><span style=\"font-size:12.0pt\"> Magnesium sulphate is used as a neuroprotective agent for the fetus in cases of imminent preterm birth (before 32 weeks of gestation). It helps in reducing the risk of cerebral palsy and other neurological impairments in premature infants. This is an established indication for the use of magnesium sulfate in obstetrics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Severe Preeclampsia</span></strong><span style=\"font-size:12.0pt\">: In cases of severe preeclampsia, magnesium sulfate is used for the prevention of seizures. It&#39;s a critical component of the management of severe preeclampsia and eclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tocolysis</span></strong><span style=\"font-size:12.0pt\">: Tocolysis refers to the use of medication to suppress premature labor. Magnesium sulfate has been used off-label as a tocolytic agent to delay preterm labor, although it&#39;s not the first-line treatment for this purpose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Severe IUGR (Intrauterine Growth Restriction)</span></strong><span style=\"font-size:12.0pt\">: IUGR refers to poor growth of the fetus while in the mother&#39;s womb during pregnancy. The management of IUGR primarily focuses on monitoring and timely delivery. Magnesium sulfate has no role in the treatment or management of IUGR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MgSO4 is used for the following obstetric indications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eclampsia &amp; severe preeclampsia </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As a tocolytic in preterm labor</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For neuroprotection in very preterm</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1<sup>st</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 53216,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13317,
    "choices": [
      {
        "id": 53229,
        "text": "<p><span style=\"font-size:12.0pt;\">An exaggerated diastolic notch is seen beyond 24 weeks on uterine artery Doppler in women at risk for developing pre-eclampsia.</span></p>"
      },
      {
        "id": 53230,
        "text": "<p><span style=\"font-size:12.0pt;\">A drop in levels of PAPP-A and PlGF is a predictor for preeclampsia.</span></p>"
      },
      {
        "id": 53231,
        "text": "<p><span style=\"font-size:12.0pt;\">Angiogenic factors sFlt-1 and s-Eng are decreased in women who are at risk of developing preeclampsia</span></p>"
      },
      {
        "id": 53232,
        "text": "<p><span style=\"font-size:12.0pt;\">Cell free DNA is increased in women who are at risk of developing preeclampsia due to accelerated apoptosis of cytotrophoblasts</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All are true regarding predictive tests for preeclampsia except?</span></p>",
    "unique_key": "Q3436563",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439045,
    "difficulty_level": "difficult",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Angiogenic factors sFlt-1 and s-Eng are decreased in women who are at risk of developing preeclampsia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Predictors of preeclampsia:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Biophysical markers</strong>: Raised PI in the uterine Artery (11 \u2013 14 weeks); notching of uterine Artery waveform (mid trimester).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Biochemical markers:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-185956.jpg\" alt=\"\" width=\"1000\" height=\"467\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">S-Flt-1 and s-Eng are <strong>Anti-angiogenic factors (Not angiogenic)</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Roll over test</strong>: 28- 32 weeks: BP is measured with patient on her side first and then she is asked to roll on her back and BP is checked again -an increase of 20mmHg in diastolic BP from lateral to supine position is a positive test \u2013 30% of such women will develop pre-eclampsia in the future. This test is not done anymore.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Angiotensin II sensitivity test</strong>: Rise in BP with Angiotensin II infusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>**If the patient is at high risk of preeclampsia, low dose aspirin (75-150 mg/ day) should be started before 16 weeks of pregnancy to prevent early onset preeclampsia**</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To understand which statement is not true regarding predictive tests for preeclampsia, let's evaluate each option:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. An exaggerated diastolic notch is seen beyond 24 weeks on uterine artery Doppler in women at risk for developing pre-eclampsia</strong>: True. An exaggerated diastolic notch in the uterine artery Doppler waveform after 24 weeks of gestation is associated with an increased risk of developing preeclampsia. This finding indicates increased resistance in the uterine arteries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. A drop in levels of PAPP-A and PlGF is a predictor for preeclampsia.</strong>: True. Lower levels of Pregnancy-Associated Plasma Protein-A (PAPP-A) and Placental Growth Factor (PlGF) are associated with an increased risk of preeclampsia. These biomarkers are involved in placental development and function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Angiogenic factors sFlt-1 and s-Eng are increased in women who are at risk of developing preeclampsia</strong>: False. Elevated levels of soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (s-Eng) are found in women at risk of developing preeclampsia. However, these are factors are anti-angiogenic and not angiogenic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cell free DNA is increased in women who are at risk of developing preeclampsia due to accelerated apoptosis of cytotrophoblasts</strong>: True. While cell-free DNA levels are increased in certain conditions during pregnancy, such as fetal chromosomal abnormalities (commonly assessed in non-invasive prenatal testing), its direct association with preeclampsia risk due to accelerated apoptosis of cytotrophoblasts is also mentioned in literature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Predictors of preeclampsia:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Biophysical markers</strong>: Raised PI in the uterine Artery (11 \u2013 14 weeks); notching of uterine Artery waveform (mid trimester).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Biochemical markers:</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-190116.jpg\" alt=\"\" width=\"1000\" height=\"467\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">S-Flt-1 and s-Eng are <strong>Anti-angiogenic factors (Not angiogenic)</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Roll over test</strong>: 28- 32 weeks: BP is measured with patient on her side first and then she is asked to roll on her back and BP is checked again -an increase of 20mmHg in diastolic BP from lateral to supine position is a positive test \u2013 30% of such women will develop pre-eclampsia in the future. This test is not done anymore.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Angiotensin II sensitivity test</strong>: Rise in BP with Angiotensin II infusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 1818, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53231,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13319,
    "choices": [
      {
        "id": 53237,
        "text": "<p><span style=\"font-size:12.0pt;\">Low salt diet</span></p>"
      },
      {
        "id": 53238,
        "text": "<p><span style=\"font-size:12.0pt;\">Calcium supplementation started prior to 12 weeks</span></p>"
      },
      {
        "id": 53239,
        "text": "<p><span style=\"font-size:12.0pt;\">Aspirin 150 mg/ day prior to 16 weeks</span></p>"
      },
      {
        "id": 53240,
        "text": "<p><span style=\"font-size:12.0pt;\">Antioxidants \u2013 ascorbic acid and \u03b1-tocopherol prior to 12 weeks</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 35-year primigravida is worried about her risk of developing preeclampsia. What is the single most important intervention to help reduce the risk in her?</span></p>",
    "unique_key": "Q8764778",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439046,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Aspirin 150 mg/ day prior to 16 weeks</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The RCOG and US preventive Services task force recommends low dose aspirin (up to 150mg/ day) prophylaxis for women at high risk for pre-eclampsia.</span></li><li><span style=\"font-size:12.0pt;\">Aspirin is the <strong>ONLY </strong>recommended measure for prevention of pre-eclampsia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">let's evaluate the proposed interventions:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Low Salt Diet</strong>: While general healthy eating is recommended during pregnancy, there's no strong evidence that a low salt diet specifically reduces the risk of preeclampsia. Traditional advice often suggested this, but recent studies have not supported it as an effective preventative measure for preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Calcium Supplementation Started Prior to 12 Weeks</strong>: Calcium supplementation can be beneficial in reducing the risk of preeclampsia, particularly in women with low dietary calcium intake. However, it's not typically highlighted as the primary preventive measure in women with a standard risk profile for preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aspirin 150 mg/ day Prior to 16 Weeks</strong>: This is the correct answer. Low-dose aspirin (usually around 75-150 mg per day) started before 16 weeks of gestation has been shown to reduce the risk of preeclampsia, especially in women with certain risk factors. Aspirin helps by improving uteroplacental blood flow and reducing inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Antioxidants \u2013 Ascorbic Acid and \u03b1-tocopherol Prior to 12 Weeks</strong>: Although the theory behind using antioxidants like vitamin C (ascorbic acid) and vitamin E (\u03b1-tocopherol) to prevent preeclampsia is related to reducing oxidative stress, clinical trials have not consistently shown these supplements to be effective in reducing the risk of preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Low-dose aspirin started before 16 weeks of gestation is a recommended intervention to reduce the risk of developing preeclampsia, particularly for women at high risk.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 1825, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53239,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13325,
    "choices": [
      {
        "id": 53261,
        "text": "<p><span style=\"font-size:12.0pt;\">Alpha-methyldopa</span></p>"
      },
      {
        "id": 53262,
        "text": "<p><span style=\"font-size:12.0pt;\">Captopril</span></p>"
      },
      {
        "id": 53263,
        "text": "<p><span style=\"font-size:12.0pt;\">Enalapril</span></p>"
      },
      {
        "id": 53264,
        "text": "<p><span style=\"font-size:12.0pt;\">Losartan</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Anti-hypertensives contra-indicated in pregnancy are all except?</span></p>",
    "unique_key": "Q6306628",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439047,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Alpha-methyldopa</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Anti-hypertensives:</strong></span><ul><li><span style=\"font-size:12.0pt;\">DOC: Labetalol (Max oral dose 2400mg/d); can be given IV in emergencies (Max IV dose is 220 mg)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Alpha methyl dopa: Greatest safety data available</strong>, 48 h for onset of action</span></li><li><span style=\"font-size:12.0pt;\">Nifedipine: CCB, short acting, oral (S/l is c/i) used in emergencies</span></li><li><span style=\"font-size:12.0pt;\">Hydralazine: for emergencies, IV</span></li><li><span style=\"font-size:12.0pt;\">Diuretics: only if pulmonary edema</span></li><li><span style=\"font-size:12.0pt;\">Beta blockers: long term use causes Growth restriction, not preferred</span></li><li><span style=\"font-size:12.0pt;\">ACE inhibitors and ARB \u2013 <strong>ABSOLUTE C/I</strong> in pregnancy as they cause fetal renal anomalies.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Let's evaluate the options provided:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Alpha-methyldopa</strong>: Alpha-methyldopa is considered safe and is one of the preferred antihypertensive medications during pregnancy. It has been widely used for many years without significant adverse effects on the fetus. Alpha-methyldopa is not contraindicated in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Captopril</strong>: Captopril, an ACE inhibitor, is contraindicated in pregnancy, especially in the second and third trimesters, due to the risk of fetal renal dysplasia, oligohydramnios, and other complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Enalapril</strong>: Enalapril is another ACE inhibitor, and like captopril, it is contraindicated in pregnancy for the same reasons.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Losartan</strong>: Losartan is an angiotensin receptor blocker (ARB) and is also contraindicated in pregnancy. ARBs have been associated with adverse fetal outcomes similar to those of ACE inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The anti-hypertensive drug of choice in pregnancy is labetalol</span></li><li><span style=\"font-size:12.0pt;\">Alpha-methyldopa is considered safe and is one of the preferred anti hypertensives in pregnancy.</span></li><li><span style=\"font-size:12.0pt;\">However, ACE inhibitors (like captopril and enalapril) and ARBs (like losartan) are contraindicated due to their potential adverse effects on the developing fetus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 438, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53261,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13326,
    "choices": [
      {
        "id": 53265,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dhaka regime </span></span></span></p>"
      },
      {
        "id": 53266,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sibai regime</span></span></span></p>"
      },
      {
        "id": 53267,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Magpie regime</span></span></span></p>"
      },
      {
        "id": 53268,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zuspan regime</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are regimes of MgSO4 for treatment of eclampsia except?</span></span></p>",
    "unique_key": "Q2067839",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439048,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Magpie regime</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Various regimes of MgSO4 for eclampsia:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pritchard Regime (most commonly used in India)</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Initial dose: 20% MgSo4- 4g IV slowly over 4 mins (1g/min) as 20 ml followed by 5g in each buttock as 10ml of 50%MgSO4</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Maintenance dose: 5g of 50% MgSO4 IM in alternate buttocks 4 hourly till 24 h or till delivery, whichever is later. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sibai regime: </span></strong></span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Loading dose 6g MgSO4 IV over 15 &ndash; 20 mins f/b IV infusion 2g/ h as maintenance dose </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recommended by ACOG</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Zuspan Regime</span></strong></span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Loading dose 4g IV MgSO4 f/b IV infusion of 1g/ h until 24 h after delivery</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Dhaka regime</span></strong></span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lower dose of MgSO4 (Half of Pritchard&rsquo;s)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Loading dose is 4g IV over 15 mins</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Following this, 3 g MgSO4 IM in each buttock 4 hourly for 24 h after administration of 1<sup>st</sup> dose. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This regime was developed with South-East Asian women&rsquo;s smaller body habitus in mind to reduce the risk of Mg toxicity as compared to Pritchard regime. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Magpie is not a regime. It was a large multicentric study to determine the usefulness of MgSO4 for prophylaxis for eclampsia in women with severe preeclampsia</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The key educational takeaway is that while there are several recognized regimens for the administration of magnesium sulfate in the management of eclampsia (like the Dhaka, Sibai, and Zuspan regimens), the &quot;Magpie regime&quot; is not one of them.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Instead, the Magpie Trial was a significant research study that helped establish the effectiveness of magnesium sulfate in this context. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1<sup>st</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 53267,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13329,
    "choices": [
      {
        "id": 53277,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Preeclampsia</span></span></span></p>"
      },
      {
        "id": 53278,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic hypertension with superimposed preeclampsia</span></span></span></p>"
      },
      {
        "id": 53279,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Eclampsia</span></span></span></p>"
      },
      {
        "id": 53280,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gestational hypertension</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 32-year-old primigravida at 39 weeks has a BP recording of 150/100 which when repeated is the same. Her baseline BP during earlier visits was 120/80 mmHg. She does not complain of headache/ blurring of vision or epigastric pain. Abdominal exam reveals a term uterus with cephalic presentation and FHR of 140 bpm. Urine albumin is nil. Which is the most likely diagnosis?</span></span></span></p>",
    "unique_key": "Q3598446",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439049,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Gestational hypertension&nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypertension in pregnancy is defined as blood pressure of 140/90 mmHg or greater on at least two separate occasions that are 6 h or more apart. The presence of edema is no longer used as a diagnostic criterion because it is so prevalent in normal pregnant women. A rise in systolic blood pressure of 30 mmHg and a rise in diastolic blood pressure of 15 mmHg are also no longer used.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In <strong><em>gestational hypertension,</em></strong> maternal blood pressure reaches 140/90 or greater for the first time during pregnancy, and proteinuria is not present. In <strong><em>preeclampsia,</em></strong> blood pressure increases to 140/90 after 20 weeks of gestation and proteinuria is present (300 mg in 24 h or 1+ protein or greater on dipstick). <strong><em>Eclampsia </em></strong>is present when women with preeclampsia develop seizures.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic hypertension</span></em></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is defined as BP &gt;140/90 mmHg before pregnancy or diagnosed before 20 weeks of gestation, or hypertension first diagnosed after 20 weeks of gestation and persistent after 12 weeks postpartum.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A woman with hypertension who develops preeclampsia is described as having chronic hypertension with superimposed preeclampsia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Let&#39;s analyse each option based on the provided scenario:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Preeclampsia</span></strong><span style=\"font-size:12.0pt\">: In this case, the woman does not have proteinuria or other systemic symptoms, making preeclampsia less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Chronic Hypertension with Superimposed Preeclampsia</span></strong><span style=\"font-size:12.0pt\">: The patient&#39;s baseline BP was normal during earlier visits, which does not suggest chronic hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Eclampsia</span></strong><span style=\"font-size:12.0pt\">: There is no mention of seizures or convulsions in this scenario, ruling out eclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Gestational Hypertension</span></strong><span style=\"font-size:12.0pt\">: This is the correct diagnosis. The woman has new-onset hypertension at 39 weeks without proteinuria or other symptoms suggestive of preeclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong><span style=\"font-size:12.0pt\">&nbsp;Gestational hypertension is characterized by new-onset hypertension after 20 weeks of gestation without proteinuria or other systemic findings associated with preeclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: page 1780, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 53280,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13332,
    "choices": [
      {
        "id": 53289,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemolysis</span></span></span></p>"
      },
      {
        "id": 53290,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elevated liver enzymes</span></span></span></p>"
      },
      {
        "id": 53291,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombocytopenia</span></span></span></p>"
      },
      {
        "id": 53292,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Retroplacental hemorrhage</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is not a part of HELLP syndrome?</span></span></span></p>",
    "unique_key": "Q3459094",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439050,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Retroplacental hemorrhage&nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HELLP Syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is an acronym for Hemolysis (H), Elevated liver enzymes (EL) and Low Platelet count (LP) of &lt; 1,00,000/mm<sup>3</sup> </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a rare complication of pregnancy induced hypertension.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It may be associated even with mild hypertension and proteinuria</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical Features</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Manifested by nausea, vomiting, epigastric or right upper quadrant pain, along with biochemical and hematological changes.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parenchymal necrosis of liver causes elevation in hepatic enzymes (AST and ALT &gt; 70 IU/L and LDH &gt; 600 IU/L).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There may be subcapsular hematoma formation (which may need CT scanning) and abnormal peripheral smear.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Eventually liver may rupture to cause sudden hypotension, due to hemoperitoneum.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let&#39;s evaluate each option to identify the one that is not a part of HELLP syndrome:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hemolysis</span></strong><span style=\"font-size:12.0pt\">: Hemolysis refers to the breakdown of red blood cells, which is a key feature of HELLP syndrome. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Elevated Liver Enzymes</span></strong><span style=\"font-size:12.0pt\">: Elevated liver enzymes indicate liver dysfunction, which is another essential component of HELLP syndrome. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Thrombocytopenia</span></strong><span style=\"font-size:12.0pt\">: Thrombocytopenia is a significant reduction in platelet count, which is the third critical component of HELLP syndrome</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Retroplacental Hemorrhage</span></strong><span style=\"font-size:12.0pt\">: This is the correct answer. Retroplacental haemorrhage, also known as placental abruption, is a separate obstetric complication that involves the detachment of the placenta from the uterine wall before delivery. While it can be a serious condition, it is not a part of HELLP syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HELLP Syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is an acronym for Hemolysis (H), Elevated liver enzymes (EL) and Low Platelet count (LP) of &lt; 1,00,000/mm<sup>3</sup> </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a rare complication of pregnancy induced hypertension.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It may be associated even with mild hypertension and proteinuria</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 1849, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 53292,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13340,
    "choices": [
      {
        "id": 53321,
        "text": "<p><span style=\"font-size:12.0pt;\">Conservative management with anti-hypertensives</span></p>"
      },
      {
        "id": 53322,
        "text": "<p><span style=\"font-size:12.0pt;\">Delivery after 34 weeks of gestation</span></p>"
      },
      {
        "id": 53323,
        "text": "<p><span style=\"font-size:12.0pt;\">Immediate delivery</span></p>"
      },
      {
        "id": 53324,
        "text": "<p><span style=\"font-size:12.0pt;\">Declare fetal demise</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A Primigravida presents at 32 weeks with pre-eclampsia. She complains of decreased fetal movements. An umbilical artery Doppler is done which is as shown in the image. What is the next best step in management?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:11.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/picture3.jpg\" alt=\"\" width=\"400\" height=\"266\"></span></p>",
    "unique_key": "Q1785759",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439051,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Immediate delivery</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given UA Doppler shows reversal of end diastolic flow, which is suggestive of impending fetal demise \u2013 so the immediate management is Delivery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Let's evaluate each option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Conservative Management with Anti-Hypertensives</strong>: While controlling maternal hypertension is important in pre-eclampsia, the primary concern in this scenario is the well-being of the fetus due to decreased movements. Conservative management alone may not address the fetal distress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Delivery After 34 Weeks of Gestation</strong>: The decision to delay delivery depends on the overall condition of both the mother and the fetus. Reversal of diastolic flow shows fetal distress and waiting until 34 weeks may not be appropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Immediate Delivery</strong>: In the presence of pre-eclampsia, decreased fetal movements and doppler suggestive of reversal of flow, immediate delivery is often indicated to ensure the well-being of the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Declare Fetal Demise:</strong> This statement is not true. Immediate delivery can prevent fetal demise</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Immediate delivery is often indicated when there are signs of fetal distress, as it is essential to ensure the well-being of the fetus. &nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Reversal of diastolic flow in the umbilical artery &nbsp;raises concerns about fetal compromise, and immediate &nbsp;delivery is crucial</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref:&nbsp; Page no 1840, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53323,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13341,
    "choices": [
      {
        "id": 53325,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">a, b, c</span></p>"
      },
      {
        "id": 53326,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">a, d, e</span></p>"
      },
      {
        "id": 53327,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">a, b</span></p>"
      },
      {
        "id": 53328,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">a, b, c, d&nbsp;&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are feature(s) of magnesium toxicity in pregnancy?</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Loss of deep tendon reflex</span></li><li><span style=\"font-size:12.0pt;\">Decreased respiratory rate</span></li><li><span style=\"font-size:12.0pt;\">Decreased urine output</span></li><li><span style=\"font-size:12.0pt;\">Hypertension</span></li><li><span style=\"font-size:12.0pt;\">Increased heart rate</span></li></ol>",
    "unique_key": "Q1353259",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439052,
    "difficulty_level": "difficult",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. a, b</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Features of Mg Toxicity are</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Loss of deep tendon reflex (Depression of patellar reflex is the earliest sign of patellar toxicity): Earliest Sign</span></li><li><span style=\"font-size:12.0pt;\">Decreased respiratory rate (&lt;12 per minute)</span></li><li><span style=\"font-size:12.0pt;\">Chest pain, heart block, pulmonary edema</span></li><li><span style=\"font-size:12.0pt;\">Cardiac arrest</span></li><li><span style=\"font-size:12.0pt;\">O<sub>2</sub> saturation monitoring (PaO2 &lt; 95%)</span></li><li><span style=\"font-size:12.0pt;\">Double vision</span></li><li><span style=\"font-size:12.0pt;\">Slurred speech</span></li><li><span style=\"font-size:12.0pt;\">Nausea-vomiting</span></li><li><span style=\"font-size:12.0pt;\">Muscular weakness</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>**Decreased urine output is not a feature of Mg toxicity. Renal failure can be seen in severe preeclampsia/ eclampsia and as Mg is excreted through the kidneys, decreased renal function can increase the Mg levels in the blood thereby leading to Mg toxicity.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus Option C) is correct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Features of Magnesium Toxicity:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Loss of deep tendon reflex (Depression of patellar reflex is the earliest sign of patellar toxicity): Earliest Sign</span></li><li><span style=\"font-size:12.0pt;\">Decreased respiratory rate (&lt;12 per minute)</span></li><li><span style=\"font-size:12.0pt;\">Chest pain, heart block, pulmonary edema</span></li><li><span style=\"font-size:12.0pt;\">Cardiac arrest</span></li><li><span style=\"font-size:12.0pt;\">O<sub>2</sub> saturation monitoring (PaO2 &lt; 95%)</span></li><li><span style=\"font-size:12.0pt;\">Double vision</span></li><li><span style=\"font-size:12.0pt;\">Slurred speech</span></li><li><span style=\"font-size:12.0pt;\">Nausea-vomiting</span></li><li><span style=\"font-size:12.0pt;\">Muscular weakness</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">**Decreased urine output is not a feature of Mg toxicity. Renal failure can be seen in severe preeclampsia/ eclampsia and as Mg is excreted through the kidneys, decreased renal function can increase the Mg levels in the blood thereby leading to Mg toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 1880, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53327,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13343,
    "choices": [
      {
        "id": 53333,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &amp; PPBS</span></span></span></span></p>"
      },
      {
        "id": 53334,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">HBA1C</span></span></span></span></p>"
      },
      {
        "id": 53335,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Urine routine for sugar</span></span></span></span></p>"
      },
      {
        "id": 53336,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">GCT</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 34-year Primigravida presents to the antenatal OPD. Her mother is a diabetic and she is screened for Diabetes at her 8 weeks antenatal visit. What was the most likely screening method used?</span></span></span></p>",
    "unique_key": "Q3747682",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439053,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. HBA1C</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">As per IADPSG guidelines, testing for Diabetes in the first trimester of pregnancy is by HBA1c or an FBS or RBS. &nbsp;(For Overt diabetes Hba1C &gt; 6.5 % or FBS &gt;126 mg/dl or RBS &gt;200 mg/dl)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Urine for sugar is not sensitive for testing for Diabetes in pregnancy as physiologic glycosuria can be present</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GCT is not used for Diabetes screening in the first trimester. It is part of screening of GDM between 24 &ndash; 28 weeks. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let&#39;s look at each option separately :</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. FBS &amp; PPBS:</span></strong><span style=\"font-size:12.0pt\"> FBS and PPBS are essential for monitoring blood sugar levels in pregnant women, but both together may typically be performed later in pregnancy or when there is suspicion of gestational diabetes. IADPSG Consensus Panel members favored use of any available certified laboratory measure of glucose (Fasting OR Random plasma glucose OR Hb A1C) for initial detection of possible cases. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. HBA1C (Hemoglobin A1C)</span></strong><span style=\"font-size:12.0pt\">: HBA1C is a blood test that provides an average of a person&#39;s blood sugar levels over the past two to three months. It is a valuable screening tool for diabetes, including in pregnant women. HBA1C can be used as an early screening method for diabetes in pregnant women, especially when there is a family history of diabetes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Urine Routine for Sugar</span></strong><span style=\"font-size:12.0pt\">: Urine routine for sugar is not the primary method for diabetes screening in pregnant women. It may be used for general monitoring but is less reliable than blood tests.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. GCT (Glucose Challenge Test)</span></strong><span style=\"font-size:12.0pt\">: GCT is typically performed later in pregnancy to screen for gestational diabetes and is not the primary method for early screening in the first trimester.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective (Summary): </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemoglobin A1C (HBA1C) is the most likely screening method used for diabetes at the 8-week antenatal visit, especially when there is a family history of diabetes. It provides a longer-term view of blood sugar control.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 1108, Williams Obstetrics 25<sup>th</sup> edition</span></span></strong></p>",
    "correct_choice_id": 53334,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13346,
    "choices": [
      {
        "id": 53345,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Anemia</span></span></span></p>"
      },
      {
        "id": 53346,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Antepartum hemorrhage</span></span></span></span></p>"
      },
      {
        "id": 53347,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gestational Diabetes mellitus</span></span></span></span></p>"
      },
      {
        "id": 53348,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Thrombocytopenia</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">An infant was born at 36 weeks of pregnancy with a birthweight 4.5 kg as shown in the image.&nbsp; Which of the following conditions is associated with this presentation?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/picture13_fMnCKOd.jpg\" style=\"height:169px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q9293144",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439054,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. C. Gestational Diabetes mellitus</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The clinical scenario shown is of macrosomia. </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Macrosomia is defined as estimated fetal weight &gt; 90<sup>th</sup> percentile for that gestational age</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Causes of macrosomia are.</span></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gestational Diabetes mellitus</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Maternal obesity</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Previous baby with macrosomia</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Post-term pregnancy</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Excessive weight gain in pregnancy</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Anemia and APH are associated with fetal growth restriction</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Thrombocytopenia has no association with fetal weight</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let&#39;s briefly explain each option:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Anemia</span></strong><span style=\"font-size:12.0pt\">: Anemia refers to a deficiency of hemoglobin in the blood and is not typically associated with macrosomia or a large birthweight.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Antepartum hemorrhage</span></strong><span style=\"font-size:12.0pt\">: Antepartum hemorrhage refers to bleeding during pregnancy before the onset of labor and is not directly associated with the infant&#39;s birthweight.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Gestational Diabetes Mellitus (GDM)</span></strong><span style=\"font-size:12.0pt\">: Infants born to mothers with GDM are at an increased risk of macrosomia, which can have implications for both mother and baby. Proper management of GDM during pregnancy is essential to reduce the risk of complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Thrombocytopenia</span></strong><span style=\"font-size:12.0pt\">: Thrombocytopenia is a condition characterized by a low platelet count in the blood and is not directly related to the infant&#39;s birthweight.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The birth of an infant with a birthweight of 4.5 kg at 36 weeks of pregnancy is suggestive of macrosomia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Macrosomia is commonly associated with maternal gestational diabetes mellitus (GDM), which can lead to larger birthweights in babies.</span></span></span></span></span></span></li>\r\n</ul>",
    "correct_choice_id": 53347,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13348,
    "choices": [
      {
        "id": 53353,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">\u2265 110 mg/dl</span></p>"
      },
      {
        "id": 53354,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">\u2265 126 mg/dl</span></p>"
      },
      {
        "id": 53355,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">\u2265 140 mg/dl</span></p>"
      },
      {
        "id": 53356,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">\u2265 200 mg/dl</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">For diagnosis of overt gestational diabetes, the fasting blood sugar (FBS] level should be?</span></p>",
    "unique_key": "Q5608824",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439055,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B. \u2265 126 mg/dl&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">IADPSG Recommendations: Testing in 2 phases</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>1<sup>st</sup> Phase: To test for overt diabetes (which the woman may be unaware of)</strong></span><br>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Done in the 1<sup>st</sup> trimester (early antenatal visit)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Test using HbA1C/ FBS/ RBS</span></li><li><span style=\"color:black;font-size:12.0pt;\">FBS \u2265 126 mg/dL</span></li><li><span style=\"color:black;font-size:12.0pt;\">HbA1C \u2265 6.5 %</span></li><li><span style=\"color:black;font-size:12.0pt;\">RBS \u2265 200 mg/dL (but this should be confirmed by FBS/ HbA1C)</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-200643.jpg\" alt=\"\" width=\"39\" height=\"58\"></span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>2<sup>nd</sup> Phase: To test for GDM</strong></span><br>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Done between 24 \u2013 28 weeks</span></li><li><span style=\"color:black;font-size:12.0pt;\">75g GTT</span></li><li><span style=\"color:black;font-size:12.0pt;\">Fasting: 92/ 1h \u2013 180/ 2h \u2013 153</span></li><li><span style=\"color:black;font-size:12.0pt;\">Any one value abnormal: Enough to diagnose GDM</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">To diagnose overt gestational diabetes, the fasting blood sugar (FBS) level should be \u2265 126 mg/dl (milligrams per decilitre).</span></li><li><span style=\"font-size:12pt;\">It's important to note that the diagnostic criteria for gestational diabetes may vary in different guidelines and regions. However, a fasting blood sugar level of \u2265 126 mg/dl is a commonly recognized threshold for diagnosing overt gestational diabetes.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xKRl68F.png\" width=\"1265\" height=\"844\"></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Ref: Page 1108, Williams Obstetrics 25<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53354,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13350,
    "choices": [
      {
        "id": 53361,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">34 weeks</span></span></span></span></p>"
      },
      {
        "id": 53362,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">37 weeks</span></span></span></span></p>"
      },
      {
        "id": 53363,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">38 weeks</span></span></span></span></p>"
      },
      {
        "id": 53364,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">40 weeks</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 34-year Primi who is a known diabetic on insulin presents at 34 weeks pregnancy.&nbsp; On examination, the uterus is 34 weeks and FHR is 140 bpm. Her blood sugar is well controlled. At what period of gestation should her delivery be planned? </span></span></span></p>",
    "unique_key": "Q3958894",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439056,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. C. 38 weeks</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">In Overt Diabetes&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">(Pre-gestational diabetes) on insulin, Plan delivery at 38 weeks OR earlier if </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Poorly controlled sugars</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Non reassuring fetal status</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">In Gestational Diabetes</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Plan delivery at 40 weeks </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Avoid past dates</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Anticipate shoulder dystocia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Prophylactic LSCS in diabetic women if estimated fetal weight &gt; 4.5 Kg</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">In Overt Diabetes (Pre-gestational diabetes) on insulin, delivery is planned at 38 weeks.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Earlier delivery may be planned if there are poorly controlled sugars or non-reassuring fetal status</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 1107, Williams Obstetrics, Page no 509, Textbook of Obstetrics by JB Dutta</span></span></span></strong></p>",
    "correct_choice_id": 53363,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13351,
    "choices": [
      {
        "id": 53365,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Insulin secretion increases in pregnancy</span></span></span></span></p>"
      },
      {
        "id": 53366,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Insulin resistance is due to placental hormones</span></span></span></span></p>"
      },
      {
        "id": 53367,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Maternal insulin can cross the placenta</span></span></span></span></p>"
      },
      {
        "id": 53368,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The fetus starts secreting insulin at 12 weeks</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">All are true regarding physiology of pregnancy except?</span></span></span></p>",
    "unique_key": "Q8357193",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439057,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. C. Maternal insulin can cross the placenta</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Carbohydrate metabolism in pregnancy</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pregnancy is a diabetogenic state associated with hyperinsulinemia and insulin resistance</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Insulin resistance is due to placental hormones (human placental lactogen, estrogen, progesterone, cortisol)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Insulin secretion increases during pregnancy</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Insulin resistance is maximum between 24-28 weeks of pregnancy</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Maternal insulin cannot cross the placenta</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The fetus starts secreting insulin by 12 weeks</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s explore each of the given options:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin Secretion Increases in Pregnancy (Option A)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: True. During pregnancy, the body&#39;s need for insulin increases due to the greater demand for glucose by both the mother and the growing fetus. The pancreas typically responds by increasing insulin production to meet these needs.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin Resistance is Due to Placental Hormones (Option B)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This statement is also true. Pregnancy is characterized by a state of insulin resistance, which worsens as pregnancy progresses. This insulin resistance is primarily driven by placental hormones such as human placental lactogen, progesterone, and others. These hormones ensure that enough glucose is available for the fetus by making the mother&#39;s body less responsive to insulin.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal Insulin Can Cross the Placenta (Answer C)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is false, and therefore the correct answer. Maternal insulin does not cross the placenta. The fetus produces its own insulin starting from around 10-12 weeks of gestation. The mother&#39;s insulin does not enter the fetal circulation; instead, the glucose crosses the placenta, and the fetus produces insulin in response to this glucose.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Fetus Starts Securing Insu lin at 12 Weeks (Option D)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a true statement. The fetal pancreas begins to function and produce insulin around the 12th week of gestation. Fetal insulin plays a crucial role in fetal growth and development, especially in the second and third trimesters.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In pregnancy, there is an increase in insulin secretion due to increased insulin resistance, largely driven by placental hormones. However, maternal insulin does not cross the placenta; the fetus produces its own insulin in response to glucose that crosses from the maternal circulation. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page 66, William&rsquo;s Obstetrics 25<sup>th</sup> edition</span></span></span></strong></p>",
    "correct_choice_id": 53367,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13352,
    "choices": [
      {
        "id": 53369,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pre-gestational diabetes</span></span></span></span></p>"
      },
      {
        "id": 53370,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gestational diabetes mellitus</span></span></span></span></p>"
      },
      {
        "id": 53371,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Effect of valproate</span></span></span></span></p>"
      },
      {
        "id": 53372,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypertensive on ACE inhibitors</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Identify the maternal condition that can lead to the findings in the baby as shown below</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/picture14_kY8nI7M.jpg\" style=\"height:307px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q2368660",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439058,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A. Pre-gestational diabetes</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">This image is mermaid syndrome or sirenomelia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It is characteristically associated with overt (pre-gestational) Diabetes mellitus.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The most common anomaly associated with overt (pre-gestational) diabetes mellitus in pregnancy is cardiac anomalies (VSD being the most common).</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s examine each of the options:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pre-gestational Diabetes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This refers to diabetes that exists before pregnancy. Women with pre-gestational diabetes have a higher risk of giving birth to babies with congenital anomalies, including neural tube defects and cardiovascular malformations.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational Diabetes Mellitus (GDM)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This type of diabetes develops during pregnancy and generally resolves after delivery. While GDM can lead to several complications, such as macrosomia or hypoglycemia in the baby, it is not typically associated with congenital anomalies.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Effect of Valproate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Valproate use during pregnancy, particularly in the first trimester, is associated with an increased risk of several congenital malformations, including neural tube defects, cleft palate, and heart defects.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertensive on ACE Inhibitors</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: ACE inhibitors are not recommended during pregnancy, as they can lead to fetal complications such as renal damage. However, there is no known association between the use of ACE inhibitors and sirenomelia.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mermaid syndrome or sirenomelia is characteristically associated with overt (pre-gestational) Diabetes mellitus.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most common anomaly associated with pre-gestational diabetes mellitus in pregnancy is cardiac anomalies (VSD being the most common).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page 1110, Williams Obstetrics 25<sup>th</sup> edition</span></span></span></strong></p>",
    "correct_choice_id": 53369,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13362,
    "choices": [
      {
        "id": 53409,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Glyburide</span></span></span></span></p>"
      },
      {
        "id": 53410,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Insulin</span></span></span></span></p>"
      },
      {
        "id": 53411,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Metformin</span></span></span></span></p>"
      },
      {
        "id": 53412,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pioglitazone</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Which hypoglycemic drug cannot be used in diabetes in pregnancy?</span></span></span></span></p>",
    "unique_key": "Q7657796",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439059,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. D. Pioglitazone</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Drugs safe in pregnancy are:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">OHA &ndash; Metformin (Category B) and Glyburide (Category C) and Insulin</span></span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Both Metformin and Glyburide cross the placenta</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Metformin: </span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Biguanide, acts by promoting glucose uptake in the periphery and the liver</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Suppresses hepatic glucose production</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypoglycemia not seen</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Started at 250 mg TDs; Max: 2500 mg/day</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Glyburide</span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases insulin secretion</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Safe after 15 weeks</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dose: 2.5 mg BD; may 20 mg/ day</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased incidence of neonatal and maternal hypoglycemia with glyburide</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s discuss each option:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glyburide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Glyburide is a sulfonylurea class of medication that increases insulin secretion from the pancreas. It is classified as Category C by the FDA, meaning that animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks. Glyburide does cross the placenta but has been used in pregnancy, particularly in the second and third trimesters. However, it may increase the risk of neonatal and maternal hypoglycemia.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Insulin is the most common and preferred treatment for managing diabetes in pregnancy, especially if the diabetes is pre-gestational. It does not cross the placenta and therefore does not pose a direct risk to the fetal development. Different types of insulin can be used to manage blood sugar levels effectively during pregnancy.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Metformin is a biguanide that decreases hepatic glucose production and increases glucose uptake in the periphery. Classified as Category B by the FDA, it suggests that there is no evidence of risk in human pregnancy. Metformin does cross the placenta, but studies have not shown an increased risk of birth defects or other pregnancy complications. It&#39;s often used in gestational diabetes and in women with polycystic ovary syndrome (PCOS) who are trying to conceive.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone (Answer D)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pioglitazone belongs to the thiazolidinedione class of drugs, which is generally not recommended during pregnancy. The safety of pioglitazone in pregnancy has not been established, and there are concerns about its potential effects on the fetus. Therefore, it is usually avoided in pregnancy.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When treating diabetes in pregnancy, insulin is the preferred medication due to its safety profile.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin and glyburide can also be used, albeit with some caution and monitoring.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone, on the other hand, is not recommended for use during pregnancy due to the lack of sufficient safety data and potential fetal risks.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 1110, Williams Obstetrics 25<sup>th</sup> edition</span></span></span></strong></p>",
    "correct_choice_id": 53412,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13364,
    "choices": [
      {
        "id": 53417,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Necrotizing enterocolitis</span></span></span></span></p>"
      },
      {
        "id": 53418,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hyperbilirubinemia</span></span></span></span></p>"
      },
      {
        "id": 53419,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Neonatal hypocalcemia</span></span></span></span></p>"
      },
      {
        "id": 53420,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Neonatal hyperglycemia</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 32-years old G3P2L2 visits an antenatal clinic at 28 weeks. She reveals during history that her first baby weighed 4.6 kg, second baby weighed 4.8 kg, and both were delivered by C-section. Neonatal complications of an infant of diabetic mother except?</span></span></span></p>",
    "unique_key": "Q8470673",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439060,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. D.&nbsp; Neonatal hyperglycemia</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Diabetes mellitus during pregnancy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Neonatal complications (Seen because of Pedersen Hypothesis)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypoglycemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Respiratory distress syndrome</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hyperbilirubinemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Necrotizing enterocolitis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Polycythemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypocalcemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypomagnesemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Cardiomyopathy</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s discuss the neonatal complications associated with infants of diabetic mothers, to understand why &quot;Neonatal hyperglycemia&quot; is the exception:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Necrotizing Enterocolitis (Option A)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While not the most common complication in infants of diabetic mothers, necrotizing enterocolitis (NEC) can occur. NEC is a serious intestinal disease that affects mostly premature infants. Infants of diabetic mothers are at risk for various complications, but NEC is not typically a direct consequence of maternal diabetes.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperbilirubinemia (Option B)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a common complication in infants of diabetic mothers. These infants often have increased red blood cell turnover, which can lead to higher levels of bilirubin and result in jaundice.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neonatal Hypocalcaemia (Option C)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Infants of diabetic mothers are at an increased risk of hypocalcemia, or low calcium levels in the blood. This can occur due to various metabolic imbalances associated with the maternal diabetic environment.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neonatal Hyperglycemia (Answer D)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is less likely in infants of diabetic mothers and thus is the correct answer. In fact, neonatal hypoglycemia is a more common issue in these infants. Due to high insulin levels in response to maternal hyperglycemia, these infants can have low blood sugar levels after birth once the maternal glucose supply is cut off.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Neonatal complications (Seen because of Pedersen Hypothesis)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypoglycemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Respiratory distress syndrome</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hyperbilirubinemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Necrotizing enterocolitis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Polycythemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypocalcemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypomagnesemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Cardiomyopathy</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:&nbsp;</span></span></span></em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Page no 1102, Williams Obstetrics 25<sup>th</sup> edition</span></span></span></strong></p>",
    "correct_choice_id": 53420,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30500,
    "choices": [
      {
        "id": 121878,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute fatty liver of pregnancy</span></span></span></p>"
      },
      {
        "id": 121879,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HELLP syndrome</span></span></p>"
      },
      {
        "id": 121880,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intrahepatic cholestasis of pregnancy</span></span></p>"
      },
      {
        "id": 121881,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute viral hepatitis</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A pregnant woman in her second trimester presents with mildly elevated liver enzymes and itching over her body. She has no history of liver disease. What is the most likely diagnosis?</span></span></span></p>",
    "unique_key": "Q8828382",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439061,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Intrahepatic cholestasis of pregnancy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Intrahepatic cholestasis of pregnancy typically presents in the second or third trimester with itching and elevated liver enzymes but without significant liver damage. It&#39;s characterized by impaired bile flow and can lead to adverse fetal outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A: Acute Fatty Liver of Pregnancy: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is diagnosed by the Swansea criteria. Patients with AFLP usually present in the 3<sup>rd</sup> trimester with jaundice, abdominal pain, vomiting. There is altered liver function along with worsening renal and coagulation parameters. Hypoglycemia is typically seen. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B: HELLP Syndrome: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a form of severe preeclampsia so a h/o high BP would usually be mentioned. HELLP syndrome is a triad of <strong>H</strong>emolysis, <strong>E</strong>levated <strong>L</strong>iver Enzymes and <strong>L</strong>ow <strong>P</strong>latelets. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D: Acute viral hepatitis: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This can be seen in any trimester. There is a history of fever, constitutional symptoms and jaundice. Serum bilirubin is raised and AST and ALT are very highly raised. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-125402.jpg\" style=\"height:458px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Reference- Page no 270, DC Dutta&rsquo;s textbook of Obstetrics, 9<sup>th</sup> edition</span></span></strong></span></span></p>",
    "correct_choice_id": 121880,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13442,
    "choices": [
      {
        "id": 53729,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It is associated with high fetal and maternal morbidity and mortality&nbsp;</span></span></span></span></p>"
      },
      {
        "id": 53730,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Commonly occurs in the 2<sup>nd</sup> trimester&nbsp;</span></span></span></span></p>"
      },
      {
        "id": 53731,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It has an association with gestational diabetes mellitus</span></span></span></span></p>"
      },
      {
        "id": 53732,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Less common in multiple pregnancies</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which of the following is true about Acute fatty liver of pregnancy? </span></span></span></p>",
    "unique_key": "Q4685840",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439062,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A. It is associated with high fetal and maternal morbidity and mortality&nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Acute Fatty Liver of Pregnancy- </span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The most frequent cause of acute liver failure during pregnancy</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">1 in 10000 pregnancies</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Recurrence &ndash; rare</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/screenshot-2023-04-30-144450.jpg\" style=\"height:634px; width:1267px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">AFLP is diagnosed by Swansea criteria where 6 out of 14 criteria are required to diagnose AFLP</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">AFLP: Swansea diagnostic criteria</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">(Six or more in the absence of other explanation)</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Vomiting </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Abdominal pain</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Polydipsia/polyuria</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Encephalopathy</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">High bilirubin &gt; 15 micromol/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypoglycemia &lt; 4 mmol/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">High uric acid &gt; 340 micromol/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Leukocytosis &gt; 11x10<sup>6</sup>/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ascites or bright liver on ultrasound</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">High AST/ALT &gt; 42 micromol/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">High ammonia &gt;47 micromol/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Renal impairment with creatinine &gt; 150 micromol/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Coagulopathy PT &gt; 14 sec</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Microvesicular steatosis on liver biopsy</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Reference- Williams Obstetrics 25<sup>th</sup> edition, Page no 1061</span></span></strong></span></span></p>",
    "correct_choice_id": 53729,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13444,
    "choices": [
      {
        "id": 53737,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Kidney increases in pregnancy by about 1.5 cm</span></span></span></span></p>"
      },
      {
        "id": 53738,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pelvicalyceal dilatation is more on the left side than the right side</span></span></span></span></p>"
      },
      {
        "id": 53739,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">An increased GFR leads to lower serum creatinine levels</span></span></span></span></p>"
      },
      {
        "id": 53740,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Glycosuria may be seen in up to 50% of pregnant women</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which is not seen in pregnancy regarding renal changes in pregnancy?</span></span></span></p>",
    "unique_key": "Q8424591",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439063,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B.&nbsp; Pelvicalyceal dilatation is more on the left side than right side</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Physiological changes in the urinary system in pregnancy</span></span></span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kidneys</span></strong></span></span></span>\r\n\r\n\t<ol style=\"list-style-type:upper-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increase in size by about 1.5 cm</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pelvicalyceal dilatation (Right &gt; left)</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased GFR leading to low creatinine, low BUN and low urea levels</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Total volume of urine passed is normal</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enzyme renin is increased</span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ureter</span></strong></span></span></span>\r\n\t<ol style=\"list-style-type:upper-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atonic, dilated (Right &gt; left)</span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bladder</span></strong></span></span></span>\r\n\t<ol style=\"list-style-type:upper-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mucosa become hyperemic and congested</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased frequency in the 1<sup>st</sup> and 3<sup>rd</sup> trimester</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SUI due to urethral sphincter weakness and decreased bladder capacity</span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glycosuria</span></strong></span></span></span>\r\n\t<ol style=\"list-style-type:upper-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">May be seen in up to 50% of pregnant women due to increase in GFR and decreases tubular reabsorption of glucose lowering the renal threshold</span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Proteinuria</span></strong></span></span></span>\r\n\t<ol style=\"list-style-type:upper-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Significant proteinuria (&gt; 300mg/24h) is seen in preeclampsia</span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n</ol>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 55, Textbook of Obstetrics by JB Sharma</span></span></strong></span></span></p>",
    "correct_choice_id": 53738,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13446,
    "choices": [
      {
        "id": 53745,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hep-B Vaccine should be administered within 24 hours of birth&nbsp;</span></p>"
      },
      {
        "id": 53746,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">HBIG should be administered within 12 hours of birth.&nbsp;</span></p>"
      },
      {
        "id": 53747,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hep-B Vaccine and HBIG should be administered within 12 hours of birth&nbsp;</span></p>"
      },
      {
        "id": 53748,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hep-B Vaccine and HBIG should be administered within 24 hours of birth&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">A 30y primigravida presents in labor at 38 weeks. The resident notes that she is HBsAg positive. Which of the following statements regarding immunization of a newborn born to a HBsAg positive mother is true?</span></p>",
    "unique_key": "Q3507898",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439064,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Hep-B Vaccine and HBIG should be administered within 12 hours of birth)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Newborn of HBSAg positive mothers: The following has to be given to reduce the risk of Hepatitis B in the neonate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Hepatitis B Immunoglobulin (HBIG) 0.5 ml IM (intramuscular) within 12 hours of birth</span></li><li><span style=\"font-size:16px;\">Active immunization with Hep B vaccine (0.5 ml) IM at a separate site at birth.</span></li><li><span style=\"font-size:16px;\">Passive + Active immunization: 85 \u2013 95% effective in preventing transmission.</span></li><li><span style=\"font-size:16px;\">Breastfeeding is not contra-indicated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_jAaFs84.png\" width=\"1033\" height=\"218\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Vaccination schedule of hepatitis B vaccine&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_GvIZhju.png\" width=\"708\" height=\"288\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Reference: Williams Obstetrics 25<sup>th</sup> edition Page 1065</strong></span></p>",
    "correct_choice_id": 53747,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13449,
    "choices": [
      {
        "id": 53757,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Abruptio placenta</span></p>"
      },
      {
        "id": 53758,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Postpartum hemorrhage</span></p>"
      },
      {
        "id": 53759,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Acute Fatty liver of Pregnancy</span></p>"
      },
      {
        "id": 53760,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hepatitis B</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">Obstetric causes of Acute Kidney Injury (AKI) in pregnancy include all except?</span></p>",
    "unique_key": "Q2400919",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439065,
    "difficulty_level": "difficult",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Hepatitis B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Causes of AKI in pregnancy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Hyperemesis gravidarum</span></li><li><span style=\"font-size:12.0pt;\">Abruptio placenta</span></li><li><span style=\"font-size:12.0pt;\">AFLP</span></li><li><span style=\"font-size:12.0pt;\">Severe preeclampsia/ eclampsia</span></li><li><span style=\"font-size:12.0pt;\">PPH</span></li><li><span style=\"font-size:12.0pt;\">Amniotic fluid embolism</span></li><li><span style=\"font-size:12.0pt;\">Thrombotic microangiopathy</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 2617, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53760,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13450,
    "choices": [
      {
        "id": 53761,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It is the most common cause of jaundice in pregnancy</span></span></span></span></p>"
      },
      {
        "id": 53762,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Itching is typically present on the palms and soles</span></span></span></span></p>"
      },
      {
        "id": 53763,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The recurrence rate in subsequent pregnancies is up to 50%</span></span></span></span></p>"
      },
      {
        "id": 53764,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It is associated with meconium staining of amniotic fluid and fetal death</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which of the following is incorrect regarding Obstetric Cholestasis?</span></span></span></p>",
    "unique_key": "Q3831714",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439066,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A. It is the most common cause of jaundice in pregnancy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Obstetric Cholestasis-</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">2<sup>nd</sup> most common cause of jaundice in pregnancy (after viral hepatitis)</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Clinical Features- </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Commonly presents in the: 3<sup>rd</sup> trimester</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pruritus </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Main symptom</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Generalized but more common on soles and palms</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Most severe at night</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Slight jaundice; Associated dark urine, pale stools, steatorrhea and malaise may be seen</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Investigations- </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Mildly raised SGOT/ SGPT (usually less than 500)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Moderately elevated ALP (Alkaline phosphatase)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Moderately elevated serum bilirubin (up to 5 mg %)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Raised serum bile acids</span></span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"list-style-type:none\">\r\n\t\t<ul style=\"list-style-type:disc\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Most specific investigation</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Values &gt; 10&micro;mol/L &ndash; indicative of increased levels; </span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Values &gt; 40&micro;mol/L &ndash; associated with poor perinatal outcome</span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Effect on Pregnancy -</span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Meconium-stained amniotic fluid; Fetal distress; Stillbirths; Increased perinatal mortality rate</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Management-</span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Symptomatic relief </span></span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li style=\"list-style-type:none\">\r\n\t\t<ul style=\"list-style-type:disc\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Emollients</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Antihistamine</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ursodeoxycholic acid: Relieves pruritus, lowers bile acid and serum liver enzyme levels</span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Obstetric Management </span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"list-style-type:none\">\r\n\t\t<ul style=\"list-style-type:disc\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Monitoring with weekly Liver function test</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">If PT-INR prolonged &ndash; offer vitamin K </span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Induction of Labor at 38 weeks can be considered.</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Antepartum and Intrapartum fetal monitoring</span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:120px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Post Delivery</span></span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Repeat LFT at 6 weeks postpartum</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Avoid Estrogen containing contraceptives</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Recurrence rate in subsequent pregnancy: high (50 &ndash; 60%)</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:120px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Reference-: Page 1059, Williams Obstetrics 25<sup>th</sup> edition</span></span></strong></span></span></p>",
    "correct_choice_id": 53761,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13452,
    "choices": [
      {
        "id": 53769,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Immediate induction of labor</span></span></span></span></p>"
      },
      {
        "id": 53770,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Emergency LSCS</span></span></span></span></p>"
      },
      {
        "id": 53771,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Monitor BP and plan delivery at 37 weeks</span></span></span></span></p>"
      },
      {
        "id": 53772,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Weekly LFT and plan delivery at 38 weeks</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 27-year G2P1L1 presents at 33 weeks with itching mainly on the palms of her hands. The itching worsens at night. She gives a similar history in her 1<sup>st</sup> pregnancy. On examination, her BP is 130/84 mmHg. There is mild icterus and abdominal examination reveals a 32 weeks uterus with fetal heart rate of 140 bpm. Her SGOT is 112 IU/L, SGPT is 124 IU/L and serum bilirubin is 2 mg%. What is the next best step in management? </span></span></span></p>",
    "unique_key": "Q3712596",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439067,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. D. Weekly LFT and plan delivery at 38 weeks</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The diagnosis is Obstetric cholestasis </span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Management</span></span></strong></span></span></p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li style=\"list-style-type:none\">\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Symptomatic relief: </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">mollients, Antihistamine, Ursodeoxycholic acid (Relieves pruritus, lowers bile acid and serum liver enzyme levels)</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Obstetric Management </span></span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Monitoring with weekly LFT, PT-INR</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">If PT-INR prolonged &ndash; offer vitamin K </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Induction of Labor at 38 weeks</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Antepartum and Intrapartum fetal monitoring</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Reference: - Williams Obstetrics 25<sup>th</sup> edition, Page no 1060</span></span></strong></span></span></p>",
    "correct_choice_id": 53772,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13458,
    "choices": [
      {
        "id": 53793,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gestational Diabetes</span></span></span></span></p>"
      },
      {
        "id": 53794,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hyperemesis gravidarum</span></span></span></span></p>"
      },
      {
        "id": 53795,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Obstetric cholestasis</span></span></span></span></p>"
      },
      {
        "id": 53796,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pre-eclampsia</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Liver dysfunction is seen in all of the following in pregnancy except?&nbsp; </span></span></span></span></p>",
    "unique_key": "Q7693249",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439068,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A. Gestational Diabetes</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/screenshot-2023-04-30-144703.jpg\" style=\"height:524px; width:1081px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">(Reference- Page no 270, DC Dutta&rsquo;s textbook of Obstetrics, 9<sup>th</sup> edition)</span></span></strong></span></span></p>",
    "correct_choice_id": 53793,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13314,
    "choices": [
      {
        "id": 53217,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&ge; 300 mg/ 24 h</span></span></span></span></p>"
      },
      {
        "id": 53218,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&ge; 30 mg/24 h</span></span></span></span></p>"
      },
      {
        "id": 53219,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&ge; 3 mg/24 h</span></span></span></span></p>"
      },
      {
        "id": 53220,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&ge; 0.3mg/ 24h</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To define preeclampsia, the proteinuria defined is?</span></span></p>",
    "unique_key": "Q1629168",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439069,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. &ge; 300 mg/ 24 h</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pre-eclampsia is defined as Hypertension plus </span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Proteinuria &ge; 300 mg/ 24h or </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urine protein: creatinine ratio &ge; 0.3 or</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dipstick 1+ or more</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">But remember, for severity of preeclampsia, proteinuria is no longer a parameter</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The diagnosis of preeclampsia involves assessing for the presence of hypertension and significant proteinuria, defined as the excretion of 300 mg or more of protein in a 24-hour urine collection. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Page no 712, Williams Obstetrics 25<sup>th</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 53217,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13316,
    "choices": [
      {
        "id": 53225,
        "text": "<p><span style=\"font-size:12.0pt;\">The diagnosis is made if BP &gt; 140/90 mmHg after 20 weeks in the absence of proteinuria</span></p>"
      },
      {
        "id": 53226,
        "text": "<p><span style=\"font-size:12.0pt;\">5-10% of eclamptic seizures develop in women with gestational hypertension</span></p>"
      },
      {
        "id": 53227,
        "text": "<p><span style=\"font-size:12.0pt;\">The diagnosis is made only if the blood pressure does not return to normal after 12 weeks postpartum</span></p>"
      },
      {
        "id": 53228,
        "text": "<p><span style=\"font-size:12.0pt;\">It is also known as transient hypertension as the BP returns to normal postpartum</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All are true regarding gestational hypertension except?</span></p>",
    "unique_key": "Q9659065",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439070,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. The diagnosis is made only if the blood pressure does not return to normal after 12 weeks postpartum</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Gestational hypertension is defined as hypertension in the absence of proteinuria &gt; 20 weeks.</span></li><li><span style=\"font-size:12.0pt;\">The BP returns to normal after 12 weeks postpartum and is hence also known by some as transient hypertension</span></li><li><span style=\"font-size:12.0pt;\">10% of eclampsia cases is seen in women with gestational HTN</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Classification of HTN in pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-184021.jpg\" alt=\"\" width=\"1000\" height=\"678\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Let's examine each statement to identify which one is not true about gestational hypertension:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. The Diagnosis is Made if BP &gt; 140/90 mmHg after 20 Weeks in the Absence of Proteinuria</strong>: True. Gestational hypertension is diagnosed when a pregnant woman has blood pressure higher than 140/90 mmHg after 20 weeks of gestation, without the presence of significant proteinuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 5-10% of Eclamptic Seizures Develop in Women with Gestational Hypertension</strong>: This statement is misleading. While women with gestational hypertension have an increased risk of developing preeclampsia, which can lead to eclampsia, the exact percentage risk of eclamptic seizures in women with gestational hypertension alone is not well-defined.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zpE4mUe.png\" width=\"1269\" height=\"171\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The Diagnosis is Made Only if the Blood Pressure Does Not Return to Normal after 12 Weeks Postpartum</strong>: False. This statement is incorrect. Gestational hypertension is characterized by high blood pressure during pregnancy that usually resolves postpartum. If high blood pressure persists after 12 weeks postpartum, it suggests chronic hypertension rather than gestational hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is Also Known as Transient Hypertension as the BP Returns to Normal Postpartum: </strong>True. Gestational hypertension is often referred to as transient hypertension of pregnancy because in most cases, the blood pressure normalizes after the delivery of the baby.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-184135.jpg\" alt=\"\" width=\"1000\" height=\"676\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: page no 711, Williams Obstetrics 25<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53227,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13320,
    "choices": [
      {
        "id": 53241,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">7 mEq/L</span></p>"
      },
      {
        "id": 53242,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">10 mEq/L</span></p>"
      },
      {
        "id": 53243,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">12 mEq/L</span></p>"
      },
      {
        "id": 53244,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">14 mEq/L</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Patellar reflexes disappear when the plasma magnesium level reaches:</span></p>",
    "unique_key": "Q1542034",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439071,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 10 mEq/L</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Eclamptic convulsions are almost always prevented or arrested by plasma magnesium levels maintained at 4 \u2013 7 mEq/L (Equivalent to 4.8 -8.4 mg/dl or 2.0 \u2013 3.5 mmol/L)</span></li><li><span style=\"font-size:12.0pt;\">In women on MgSO4 for treatment of eclampsia/ severe pre-eclampsia, they have to be monitored very carefully for signs of Mg toxicity</span></li><li><span style=\"font-size:12.0pt;\">Mg toxicity is a cause for concern</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_hxDBECp.png\" width=\"1120\" height=\"337\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Remember: Disappearance of Deep tendon (Patellar) reflexes are the 1<sup>st</sup> sign of Mg toxicity</span></li><li><span style=\"font-size:12.0pt;\">Antidote: Calcium gluconate or calcium chloride \u2013 1 g IV</span></li><li><span style=\"font-size:12.0pt;\">Monitoring of patient on MgSO4: Check</span><ol><li><span style=\"font-size:12.0pt;\">Patellar reflex</span></li><li><span style=\"font-size:12.0pt;\">Respiratory Rate</span></li><li><span style=\"font-size:12.0pt;\">Urine output (Mg is excreted through the kidneys, so ARF can impair Mg excretion leading to Mg toxicity)</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Monitoring for magnesium toxicity is crucial when administering magnesium sulfate, especially in obstetric settings for conditions like preeclampsia or eclampsia.</span></li><li><span style=\"font-size:12.0pt;\">The loss of deep tendon reflexes, such as the patellar reflex, is the first clinical sign and usually occurs at plasma magnesium levels around 10 mEq/L.</span></li></ul>",
    "correct_choice_id": 53242,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13322,
    "choices": [
      {
        "id": 53249,
        "text": "<p><span style=\"font-size:12.0pt;\">Amlodipine</span></p>"
      },
      {
        "id": 53250,
        "text": "<p><span style=\"font-size:12.0pt;\">Labetalol</span></p>"
      },
      {
        "id": 53251,
        "text": "<p><span style=\"font-size:12.0pt;\">Captopril</span></p>"
      },
      {
        "id": 53252,
        "text": "<p><span style=\"font-size:12.0pt;\">Nifedipine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 25-year-old P2L2 had just delivered following induction for severe preeclampsia. Her BP on the 2<sup>nd</sup> postnatal day is 160/100mmHg. Which anti-hypertensive should be avoided in a breastfeeding mother?</span></p>",
    "unique_key": "Q9265562",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439072,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Amlodipine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Antihypertensive agents with no known adverse effects on infants receiving breast milk:<strong> Mnemonic: ECLAM-N</strong></span><ul><li><span style=\"font-size:12.0pt;\">Enalapril</span></li><li><span style=\"font-size:12.0pt;\">Captopril</span></li><li><span style=\"font-size:12.0pt;\">Labetalol</span></li><li><span style=\"font-size:12.0pt;\">Atenolol</span></li><li><span style=\"font-size:12.0pt;\">Metoprolol</span></li><li><span style=\"font-size:12.0pt;\">Nifedipine</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Antihypertensive agents with insufficient evidence on infant safety in breast-feeding (not recommended in breast feeding mothers):</span><ul><li><span style=\"font-size:12.0pt;\">Angiotensin receptor blocking agents</span></li><li><span style=\"font-size:12.0pt;\">Amlodipine</span></li><li><span style=\"font-size:12.0pt;\"><strong>ACE-Inhibitors (Except enalapril and captopril)</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Let's review each option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Amlodipine</strong>: Amlodipine, a calcium channel blocker, is generally not the preferred choice in breastfeeding mothers. This is the correct answer. Given the limited data and the existence of safer alternatives, amlodipine is often avoided or used with caution in breastfeeding mothers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Labetalol</strong>: Labetalol, a beta-blocker, is considered safe for use in breastfeeding mothers. It does not significantly pass into breast milk and is commonly used for managing hypertension in postpartum women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Captopril</strong>: Captopril, an ACE inhibitor, is generally considered safe in breastfeeding mothers. Captopril can be used for managing hypertension in a breastfeeding mother, though close monitoring is recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nifedipine</strong>: Nifedipine, another calcium channel blocker, is considered safe for use in breastfeeding mothers. It is excreted into breast milk in small amounts and is commonly used in postpartum hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Antihypertensive agents with no known adverse effects on infants receiving breast milk:<strong> Mnemonic: ECLAM-N</strong></span><ul><li><span style=\"font-size:12.0pt;\">Enalapril</span></li><li><span style=\"font-size:12.0pt;\">Captopril</span></li><li><span style=\"font-size:12.0pt;\">Labetalol</span></li><li><span style=\"font-size:12.0pt;\">Atenolol</span></li><li><span style=\"font-size:12.0pt;\">Metoprolol</span></li><li><span style=\"font-size:12.0pt;\">Nifedipine</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Smith, M&nbsp;,&nbsp;Waugh, J,&nbsp;Nelson\u2010Piercy, C&nbsp;Management of postpartum hypertension&nbsp;The Obstetrician &amp; Gynecologist&nbsp;2013;&nbsp;15:&nbsp;45\u2013&nbsp;50</strong></span></p>",
    "correct_choice_id": 53249,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13323,
    "choices": [
      {
        "id": 53253,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stop Telmisartan 3 months prior to conception and re-start it at the 3<sup>rd</sup> month of pregnancy</span></span></span></p>"
      },
      {
        "id": 53254,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stop Telmisartan 3 months pre-conceptionally and start Labetalol </span></span></span></p>"
      },
      {
        "id": 53255,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continue Telmisartan </span></span></span></p>"
      },
      {
        "id": 53256,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continue Telmisartan and add Labetalol if BP is uncontrolled in pregnancy</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 37-year lady with chronic hypertension visits the gynecologist for pre-conceptional counselling. She is currently taking Telmisartan for her hypertension. Which is the correct statement?</span></span></span></p>",
    "unique_key": "Q5094547",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439073,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Stop Telmisartan 3 months pre-conceptionally and start Labetalol </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Preconceptionally, women who are chronic HTN need to be</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Assesses for ventricular hypertrophy, retinopathy and renal disease</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Discuss medicine teratogenicity (ACE-I, ARBs, diuretics and beta blockers are contra-indicated in pregnancy)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Optimize BP control</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Switch to an agent appropriate for pregnancy (labetalol, calcium channel blockers)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ACE inhibitors and Angiotensin Receptor Blockers (like Telmisartan) cause fetal renal hypoplasia and lead to early onset oligohydramnios as the fetal kidneys are not formed. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Let&#39;s assess each statement regarding Telmisartan:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Stop Telmisartan 3 months prior to conception and re-start it at the 3rd month of pregnancy</span></strong><span style=\"font-size:12.0pt\">: This advice is incorrect. Telmisartan is an angiotensin receptor blocker (ARB) and is contraindicated in pregnancy due to the risk of causing fetal harm. It should not be restarted during pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Stop Telmisartan 3 months pre-conceptionally and start Labetalol</span></strong><span style=\"font-size:12.0pt\">: This is the correct answer. ARBs like Telmisartan are contraindicated in pregnancy due to their association with fetal renal dysplasia, oligohydramnios, and other complications. Labetalol is a safer alternative for managing hypertension in women who are planning to conceive and during pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Continue Telmisartan</span></strong><span style=\"font-size:12.0pt\">: Incorrect. ARBs are contraindicated in pregnancy due to potential fetal risks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Continue Telmisartan and add Labetalol if BP is uncontrolled in pregnancy</span></strong><span style=\"font-size:12.0pt\">: Incorrect.<strong> </strong>Telmisartan should not be used during pregnancy</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ACE inhibitors and Angiotensin Receptor Blockers (like Telmisartan) cause fetal renal hypoplasia and lead to early onset oligohydramnios as the fetal kidneys are nor formed and are therefore contra-indicated in pregnancy. &nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Page no 438, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 53254,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13345,
    "choices": [
      {
        "id": 53341,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">The patient has diabetes</span></p>"
      },
      {
        "id": 53342,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">The patient has a urine infection</span></p>"
      },
      {
        "id": 53343,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">The patient\u2019s urinalysis is consistent with normal pregnancy</span></p>"
      },
      {
        "id": 53344,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">The patient\u2019s urine sample is contaminated.</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">During a routine antenatal visit, an 24-year G1 at 20 weeks gestational age undergoes a urinalysis. The dipstick done indicates the presence of glycosuria. All other parameters of the urine test are normal. Which of the following is the most likely etiology of sugar detected in the urine?</span></p>",
    "unique_key": "Q9145408",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439074,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C. The patient\u2019s urinalysis is consistent with normal pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">In pregnancy, the increased GFR and the impaired tubular reabsorption capacity for filtered glucose occurs; hence glycosuria is a normal finding in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Let's explain each of the options :</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. The patient has diabetes:</strong> Glycosuria is a potential indicator of diabetes, but not a diagnostic of GDM and further diagnostic tests like fasting blood sugar (FBS), oral glucose tolerance test (OGTT), or HbA1c may be required to confirm the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. The patient has a urine infection</strong>: Urinary tract infections (UTIs) can sometimes cause glycosuria due to the presence of bacteria in the urinary tract that can ferment glucose, leading to its appearance in the urine. If a urine infection is suspected, further tests such as a urine culture and sensitivity should be performed to confirm the presence of infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The patient\u2019s urinalysis is consistent with normal pregnancy</strong>: During pregnancy, some women may develop mild glycosuria as a normal physiological response to hormonal changes. This is known as \"physiological glycosuria\" and is not associated with diabetes or other medical conditions. It is a benign condition in pregnancy and does not necessarily indicate diabetes. It typically resolves after pregnancy. Monitoring blood glucose levels may still be advisable to rule out diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. The patient\u2019s urine sample is contaminated:</strong> Contamination of the urine sample with glucose-containing substances (e.g., vaginal secretions) can lead to false-positive results for glycosuria. Careful collection and handling of urine samples are essential to ensure accurate test results. Contamination should be minimized to obtain reliable urinalysis results.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Physiological glycosuria, a normal response to hormonal changes in pregnancy, may lead to the presence of glucose in the urine without underlying diabetes.<strong> </strong>It is essential to consider other factors, such as diabetes, urinary tract infections, and sample contamination, and perform further tests if necessary to determine the cause of glycosuria.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Ref: Page 66, William\u2019s Obstetrics 25<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53343,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13349,
    "choices": [
      {
        "id": 53357,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Malformations</span></span></span></span></p>"
      },
      {
        "id": 53358,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Polyhydramnios</span></span></span></span></p>"
      },
      {
        "id": 53359,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Obesity</span></span></span></span></p>"
      },
      {
        "id": 53360,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Previous history of macrosomia</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Which is NOT seen in gestational diabetes mellitus?</span></span></span></span></p>",
    "unique_key": "Q1117456",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439075,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A. Malformations</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Congenital anomalies are NOT SEEN with GDM</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Congenital anomalies are seen Only with Overt DM</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">HbA1C &gt; 10 in the 1<sup>st</sup> trimester: Associated with a higher risk for congenital malformations</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Most Common system involved &ndash; cardiac</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Most common anomaly seen in GDM &ndash; VSD</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Most characteristic anomaly (very rare)&ndash; Mermaid syndrome/ sirenomelia</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let&#39;s briefly explain the other options:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Polyhydramnios:</span></strong><span style=\"font-size:12.0pt\"> Polyhydramnios refers to an excess of amniotic fluid in the amniotic sac during pregnancy. It can be a complication associated with GDM, as elevated blood sugar levels in the baby can lead to increased urine production, which, in turn, can contribute to polyhydramnios.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Obesity</span></strong><span style=\"font-size:12.0pt\">: Obesity is a risk factor for the development of GDM. Women who are overweight or obese before pregnancy are at a higher risk of developing GDM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Previous history of macrosomia</span></strong><span style=\"font-size:12.0pt\">: A previous history of giving birth to a macrosomic (large birthweight) baby is a risk factor for GDM. Macrosomia is a common outcome of GDM, and women who have previously experienced it are at an increased risk of developing GDM in subsequent pregnancies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gestational diabetes mellitus (GDM) is typically not associated with congenital malformations</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;GDM can lead to complications such as polyhydramnios, especially if blood sugar levels are uncontrolled during pregnancy.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Obesity is a risk factor for the development of GDM and a previous history of giving birth to a macrosomic baby increases the risk of GDM in subsequent pregnancies.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref:&nbsp; Page no 1110, Williams Obstetrics 25<sup>th</sup> edition</span></span></strong></span></span></p>",
    "correct_choice_id": 53357,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13354,
    "choices": [
      {
        "id": 53377,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Maternal hyperglycemia leads to fetal hyperglycemia resulting in fetal hyperinsulinemia and related complications</span></span></span></span></p>"
      },
      {
        "id": 53378,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Maternal insulin can cross the placenta resulting in neonatal hypoglycemia</span></span></span></span></p>"
      },
      {
        "id": 53379,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Maternal hyperglycemia results in an increased incidence of congenital anomalies</span></span></span></span></p>"
      },
      {
        "id": 53380,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Fetal hyperinsulinemia results in a lower incidence of respiratory distress syndrome</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pederson&rsquo;s hypothesis states that: </span></span></span></span></p>",
    "unique_key": "Q6504783",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439076,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A. Maternal hyperglycemia leads to fetal hyperglycemia resulting in fetal hyperinsulinemia and related complications.</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s look at each option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal Hyperglycemia Leading to Fetal Hyperglycemia and Fetal Hyperinsulinemia (Answer A)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is true. &nbsp;Pederson&#39;s hypothesis primarily states that maternal hyperglycemia leads to fetal hyperglycemia, as glucose crosses the placenta. In response to this excess glucose, the fetal pancreas produces more insulin. This overproduction of insulin can lead to several complications in the fetus, such as macrosomia, increased risk of birth injuries, and neonatal hypoglycemia after birth.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal Insulin Crossing the Placenta Resulting in Neonatal Hypoglycemia (Option B)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. Insulin, being a large molecule, does not cross the placenta. Therefore, maternal insulin levels do not directly affect the fetus. The hypoglycemia seen in neonates of diabetic mothers is typically due to the baby&#39;s own insulin response to high glucose levels in utero.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal Hyperglycemia Results in Increased Incidence of Congenital Anomalies (Option C)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While this statement is true, it is not what Pederson&#39;s hypothesis is about. Poorly controlled diabetes in the mother can increase the risk of various congenital anomalies in the fetus, particularly if the hyperglycemia occurs during the critical first trimester of organogenesis.</span></span></span><br />\r\n\t&nbsp;</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal Hyperinsulinemia Results in a Lower Incidence of Respiratory Distress Syndrome (Option D)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option is incorrect. In fact, infants of diabetic mothers, especially those with poor glycaemic control, are at an increased risk of respiratory distress syndrome. This is due to delayed lung maturity, partly influenced by insulin&#39;s antagonistic effect on surfactant production.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pederson&#39;s hypothesis emphasizes the direct impact of maternal hyperglycemia on the fetus, leading to fetal hyperglycemia and resultant fetal hyperinsulinemia.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;This cascade underscores the importance of strict glycemic control in pregnant women with diabetes to prevent fetal complications, including macrosomia, birth injuries, and neonatal hypoglycemia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-100917.jpg\" style=\"height:828px; width:968px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 1102, Williams Obstetrics 25<sup>th</sup> edition</span></span></strong></span></span></p>",
    "correct_choice_id": 53377,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13355,
    "choices": [
      {
        "id": 53381,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Caudal regression syndrome is a commonly associated anomaly seen in diabetes</span></p>"
      },
      {
        "id": 53382,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">The risk of anomalies in the fetus is inversely proportional to the level of HBA1c.</span></p>"
      },
      {
        "id": 53383,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Folic acid in a dose of 5 mg/day started in the preconception period will not reduce the risk of neural tube defects.</span></p>"
      },
      {
        "id": 53384,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Metformin and Glyburide can be safely continued in pregnancy even though they cross the placenta.</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">A 36-year diabetic woman on insulin is planning conception. She is worried about the risk of fetal congenital anomalies and visits for preconception counseling. Which of the following is the correct statement?</span></p>",
    "unique_key": "Q7929872",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439077,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D. Metformin and Glyburide can be safely continued in pregnancy even though they cross the placenta.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">The most common anomaly in diabetic mothers is congenital heart disease</span></li><li><span style=\"color:black;font-size:12.0pt;\">The most specific (albeit rare) anomaly in diabetic mothers is caudal regression syndrome (mermaid syndrome)</span></li><li><span style=\"color:black;font-size:12.0pt;\">The higher the HBA1C level preconceptionally; the higher the risk of fetal anomalies</span></li><li><span style=\"color:black;font-size:12.0pt;\">Both metformin and glyburide cross the placenta but evidence has shown they are safe</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Let's analyse each option:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Caudal Regression Syndrome is Commonly Associated with Diabetes</strong>: Caudal regression syndrome, a rare disorder characterized by abnormal development of the lower spine, is indeed more common in infants born to mothers with pre-existing diabetes, particularly those with poor glycemic control. However, it's important to note that while the risk is increased, the condition itself is still relatively rare.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Risk of Anomalies Inversely Proportional to HbA1c Levels</strong>: This statement is partially true. Higher HbA1c levels, indicating poorer blood sugar control, are associated with an increased risk of congenital anomalies. However, this option is slightly misleading as it implies a direct inverse proportionality, which is an oversimplification. The relationship between HbA1c and risk is significant, but other factors also play a role.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Folic Acid at 5 mg/day Will Not Reduce Risk of Neural Tube Defects</strong>: This statement is incorrect. Folic acid supplementation, typically at a dose of 400-800 micrograms per day, is known to reduce the risk of neural tube defects. In some cases, such as in women with a history of a child with a neural tube defect or those on certain medications like antiepileptics, a higher dose like 5 mg/day might be recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Metformin and Glyburide Safe in Pregnancy (Answer D)</strong>: Metformin and glyburide are oral hypoglycemic agents that can indeed cross the placenta. However, current evidence suggests that they are safe to use during pregnancy and are often prescribed to manage gestational diabetes or pre-existing diabetes in pregnant women. This is the correct statement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">While higher HbA1c levels are associated with increased risks, the use of certain oral hypoglycemic agents like metformin and glyburide is considered safe during pregnancy.</span></li><li><span style=\"font-size:12pt;\">Additionally, folic acid supplementation is important for reducing the risk of neural tube defects.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Ref:&nbsp; Page no 1110, Williams Obstetrics 25<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53384,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13357,
    "choices": [
      {
        "id": 53389,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">It is done in the fasting state</span></p>"
      },
      {
        "id": 53390,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Patients with a positive GCT are subjected to a GTT (Glucose tolerance test)</span></p>"
      },
      {
        "id": 53391,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">The lower the threshold taken in a GCT, the higher the sensitivity for detection of gestational diabetes mellitus</span></p>"
      },
      {
        "id": 53392,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">It is done between 24 \u2013 28 weeks</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">A 23-year primigravida presents to the OPD at 24 weeks. She is advised to get a Glucose Challenge Test done. All are true regarding the glucose challenge test (GCT) except?</span></p>",
    "unique_key": "Q3569891",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439078,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A. It is done in the fasting state.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Glucose Challenge Test (GCT)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Done at 24 \u2013 28 weeks.</span></li><li><span style=\"font-size:16px;\">Plasma glucose is measured 1 h after a 50g glucose load irrespective of prandial state.</span></li><li><span style=\"font-size:16px;\">Value of&nbsp;</span><ul><li><span style=\"font-size:16px;\">\u2265 140 mg/ dl: screen positive: subjected to glucose tolerance test (GTT)</span></li><li><span style=\"font-size:16px;\">\u2265 200: Diagnosed as GDM (No need for GTT)</span></li><li><span style=\"font-size:16px;\">The lower the threshold of GCT, the higher the sensitivity and lower the specificity for detecting gestational diabetes.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Let's evaluate the options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. It is done in the fasting state (Answer A)</strong>: This statement is incorrect, and therefore the answer. The GCT is a non-fasting test. The pregnant woman is given a glucose solution to drink, and her blood sugar level is tested after one hour. The fasting state is not required for this test, distinguishing it from the Glucose Tolerance Test (GTT).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Patients with a positive GCT are subjected to a GTT&nbsp;</strong></span><span style=\"background-color:transparent;font-size:16px;\"> <strong>(glucose tolerance test)</strong></span><span style=\"font-size:16px;\">: This statement is correct. If the GCT results are positive or above a certain threshold, it suggests the possibility of gestational diabetes, and the patient is then advised to undergo a GTT for confirmation. The GTT is a more comprehensive test involving fasting and multiple blood sugar measurements over a few hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. The lower the threshold in a GCT, the higher the sensitivity for detection of GDM</strong>: This is also correct. Lowering the threshold level for GCT results means more women will be classified as having a positive screen, increasing the sensitivity of the test. However, this might also lead to a higher false-positive rate, where women without GDM are identified as potentially having it.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. It is done between 24 \u2013 28 weeks</strong>: This is a true statement. The GCT is typically performed between 24 and 28 weeks of gestation. This timing is chosen because gestational diabetes usually develops around this period in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">The Glucose Challenge Test is a non-fasting, initial screening test for gestational diabetes conducted between 24 to 28 weeks of pregnancy.</span></li><li><span style=\"font-size:16px;\">A positive GCT necessitates further testing with a Glucose Tolerance Test. Adjusting the threshold level of the GCT can impact its sensitivity and specificity for detecting gestational diabetes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Page no 262, DC Dutta's Textbook of Obstetrics 9<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53389,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13360,
    "choices": [
      {
        "id": 53401,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &ge; 126 mg/dL</span></span></span></span></p>"
      },
      {
        "id": 53402,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">PPBS &ge; 140 mg/dl</span></span></span></span></p>"
      },
      {
        "id": 53403,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">HbA1C &ge; 6.5 %</span></span></span></span></p>"
      },
      {
        "id": 53404,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">RBS &ge; 200 mg/dL</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">As per IADPSG recommendations, pre-gestational diabetes is diagnosed in the 1<sup>st</sup> antenatal visit by all of the values given below except?</span></span></span></p>",
    "unique_key": "Q7406735",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439079,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B. PPBS &ge; 140 mg/dl</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">IADPSG Recommendations: Testing in 2 phases</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">1<sup>st</sup> Phase: To test for overt diabetes (which the woman may be unaware of)</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Done in the 1<sup>st</sup> trimester (early antenatal visit)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Test using HbA1C/ FBS/ RBS</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">FBS &ge; 126 mg/dL</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HbA1C &ge; 6.5 %</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RBS &ge; 200 mg/dL (but this should be confirmed by FBS/ HbA1C)</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">2<sup>nd</sup> Phase: To test for GDM </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Done between 24 &ndash; 28 weeks</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">75g GTT</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fasting: 92/ 1h &ndash; 180/ 2h &ndash; 153</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Any one value abnormal: Enough to diagnose GDM</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In diagnosing pre-gestational diabetes during the first antenatal visit, IADPSG guidelines include criteria such as a fasting blood sugar of &ge; 126 mg/dL, an HbA1c of &ge; 6.5%, or a random blood sugar of &ge; 200 mg/dL. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;Ref: Page 1108, Williams Obstetrics 25<sup>th</sup> edition</span></span></span></strong></p>",
    "correct_choice_id": 53402,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13361,
    "choices": [
      {
        "id": 53405,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;<span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &lt; 95 mg/dL, 1h PP &lt; 140 mg/dL, 2h PP &lt; 120 mg/dL</span></span></span></span></p>"
      },
      {
        "id": 53406,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &lt; 90 mg/dl, 1h PP &lt; 145 mg/ dl, 2h &lt; 125 mg/dl</span></span></span></span></p>"
      },
      {
        "id": 53407,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &lt; 105 mg/dl, 1h PP &lt; 140 mg/dl, 2h PP &lt; 120 mg/dl</span></span></span></span></p>"
      },
      {
        "id": 53408,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &lt; 95 mg/dl, 1h PP &lt; 120 mg/ dl, 2h PP &lt; 140 mg/dl</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Target blood glucose levels for women with gestational diabetes on treatment are:</span></span></span></span></p>",
    "unique_key": "Q7753352",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439080,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A.&nbsp; FBS &lt; 95 mg/dL, 1h PP &lt; 140 mg/dL, 2h PP &lt; 120 mg/dL</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The target blood glucose levels in treatment of diabetes in pregnancy is:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">FBS &lt; 95 mg/dL</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&nbsp;1h PP &lt; 140 mg/dL</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&nbsp;2h PP &lt; 120 mg/dL</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These targets are designed to balance the need for tight glucose control to prevent fetal complications while minimizing the risk of maternal hypoglycemia. It&#39;s important for women with gestational diabetes to monitor their blood glucose levels regularly and adhere to their treatment plan, which may include diet modifications, exercise, and possibly medication.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For the management of gestational diabetes, target blood glucose levels are set to ensure both maternal and fetal well-being. The recommended targets are:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;fasting blood sugar less than 95 mg/dL</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-hour postprandial less than 140 mg/dL</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2-hour postprandial less than 120 mg/dL. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 264, DC Dutta&rsquo;s Textbook of Obstetrics 9<sup>th</sup> edition</span></span></span></strong></p>",
    "correct_choice_id": 53405,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13328,
    "choices": [
      {
        "id": 53273,
        "text": "<p><span style=\"font-size:12.0pt;\">Cut short the 2<sup>nd</sup> stage of labor</span></p>"
      },
      {
        "id": 53274,
        "text": "<p><span style=\"font-size:12.0pt;\">Prophylactic methylergometrine at the delivery of anterior shoulder</span></p>"
      },
      {
        "id": 53275,
        "text": "<p><span style=\"font-size:12.0pt;\">Restrict IV fluids</span></p>"
      },
      {
        "id": 53276,
        "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin 10U IM following delivery</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">All the following precautions are taken in labor in a woman with pre-eclampsia except?</span></p>",
    "unique_key": "Q4767695",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439081,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Prophylactic methylergometrine at the delivery of anterior shoulder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Precautions to be taken in labor in women with pre-eclampsia</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Restrict IV fluids to avoid pulmonary edema</span></li><li><span style=\"font-size:12.0pt;\">Cut short 2<sup>nd</sup> stage of labor using instrumental delivery</span></li><li><span style=\"font-size:12.0pt;\">Avoid methylergometrine at delivery of anterior shoulder</span></li><li><span style=\"font-size:12.0pt;\">Active management of 3<sup>rd</sup> stage of labor including Oxytocin 10IU IM</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Let's examine each option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cut Short the 2nd Stage of Labor</strong>: True. In cases of pre-eclampsia, it may be necessary to shorten the second stage of labor to reduce stress on the mother. This can be achieved through instrumental delivery if needed and if there are no contraindications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Prophylactic Methylergometrine at the Delivery of Anterior Shoulder</strong>: This is the correct answer. Methylergometrine, a uterotonic, is generally avoided in women with pre-eclampsia due to its potential to elevate blood pressure. <strong>The use of methylergometrine is contraindicated in hypertensive disorders due to the risk of exacerbating hypertension.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Restrict IV Fluids</strong>: True. Fluid management is critical in pre-eclampsia. Overloading with IV fluids can increase the risk of pulmonary edema, a complication of pre-eclampsia, especially when there is accompanying capillary leakage and reduced plasma oncotic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Oxytocin 10U IM following Delivery</strong>: True. Administering oxytocin post-delivery is a standard practice to facilitate uterine contraction and reduce the risk of postpartum haemorrhage. Oxytocin is preferred over ergometrine in pre-eclampsia cases due to its lesser effect on blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Precautions to be taken in labor in women with pre-eclampsia</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Restrict IV fluids to avoid pulmonary edema</span></li><li><span style=\"font-size:12.0pt;\">Cut short 2<sup>nd</sup> stage of labor using instrumental delivery</span></li><li><span style=\"font-size:12.0pt;\">Avoid methylergometrine at delivery of anterior shoulder</span></li><li><span style=\"font-size:12.0pt;\">Active management of 3<sup>rd</sup> stage of labor including Oxytocin 10IU IM</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: page no 440, Textbook of Obstetrics, Dr JB Sharma 1<sup>st</sup> edition</strong></span></p>",
    "correct_choice_id": 53274,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13331,
    "choices": [
      {
        "id": 53285,
        "text": "<p><span style=\"font-size:12.0pt;\">New onset proteinuria</span></p>"
      },
      {
        "id": 53286,
        "text": "<p><span style=\"font-size:12.0pt;\">Platelet count &lt; 75,000</span></p>"
      },
      {
        "id": 53287,
        "text": "<p><span style=\"font-size:12.0pt;\">Increase in systolic BP by 30mm Hg and diastolic by 15 mm Hg</span></p>"
      },
      {
        "id": 53288,
        "text": "<p><span style=\"font-size:12.0pt;\">Fresh retinal hypertensive changes</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">All of the following indicate superimposed pre-eclampsia in a pregnant female of chronic hypertension except:</span></p>",
    "unique_key": "Q7813793",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439082,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Increase in systolic BP by 30mm Hg and diastolic by 15 mm Hg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-192932.jpg\" alt=\"\" width=\"1000\" height=\"455\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Let's assess each option to determine which one does not indicate superimposed pre-eclampsia:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. New Onset Proteinuria</strong>: The development of new-onset proteinuria in a pregnant woman with chronic hypertension can be a sign of superimposed pre-eclampsia. It is one of the criteria for diagnosing this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Platelet Count &lt; 75,000</strong>: A significant drop in platelet count, known as thrombocytopenia, can be an indication of superimposed pre-eclampsia. It is a concerning feature associated with this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Increase in Systolic BP by 30 mm Hg and Diastolic by 15 mm Hg</strong>: This is the correct answer. An increase in systolic blood pressure by 30 mm Hg and diastolic blood pressure by 15 mm Hg from baseline <strong>may indicate worsening hypertension in a pregnant woman but does not specifically indicate superimposed pre-eclampsia. Instead, it suggests poorly controlled chronic hypertension or exacerbation of hypertension.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Fresh Retinal Hypertensive Changes</strong>: The presence of fresh retinal hypertensive changes is a concerning sign and may indicate superimposed pre-eclampsia</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The diagnosis of chronic HTN with superimposed preeclampsia is made when a woman with chronic essential hypertension develops any of the above maternal organ dysfunction consistent with preeclampsia. Rises in BP per se are not sufficient to diagnose superimposed preeclampsia, as such rises are difficult to distinguish from the usual increase in BP after 20 weeks\u2019 gestation. In the absence of preexisting proteinuria, new-onset proteinuria in the setting of a rise in BP is sufficient to diagnose superimposed preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-193029.jpg\" alt=\"\" width=\"1000\" height=\"455\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Page no 1780, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 53287,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13363,
    "choices": [
      {
        "id": 53413,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&gt; 4000g</span></span></span></span></p>"
      },
      {
        "id": 53414,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&gt; 4500g</span></span></span></span></p>"
      },
      {
        "id": 53415,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&gt; 5000g</span></span></span></span></p>"
      },
      {
        "id": 53416,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&gt; 5500g</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Elective cesarean delivery is indicated in a diabetic woman if the estimated fetal weight is</span></span></span></p>",
    "unique_key": "Q3470343",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439083,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B. &gt; 4500g</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">As per the ACOG (to prevent shoulder dystocia)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Elective LSCS is done in non-diabetic women if the estimated fetal weight is &gt; 5kg</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Elective LSCS is done in diabetic women if the estimated fetal weight is &gt; 4.5kg</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The increased risk in diabetic pregnancies is attributed to the higher incidence of fetal macrosomia, often a result of poorly controlled maternal blood glucose levels. Macrosomia increases the risk of complications during vaginal delivery, including shoulder dystocia, where the baby&#39;s shoulder becomes lodged behind the mother&#39;s pelvic bone during delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per ACOG, for diabetic pregnant women, an elective cesarean delivery is recommended if the estimated fetal weight exceeds 4.5 kg. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is in contrast to non-diabetic women, where the threshold for an elective cesarean is set at an estimated fetal weight of more than 5 kg. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The lower threshold for diabetic women is due to the increased risk of macrosomia and related birth complications, including shoulder dystocia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page 859, Williams Obstetrics 25<sup>th</sup> edition</span></span></span></strong></p>",
    "correct_choice_id": 53414,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30496,
    "choices": [
      {
        "id": 121862,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elective cesarean delivery regardless of the presence of lesions at the time of labor</span></span></p>"
      },
      {
        "id": 121863,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginal delivery if there are no active lesions at the time of labor</span></span></p>"
      },
      {
        "id": 121864,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginal delivery with administration of antiviral prophylaxis</span></span></p>"
      },
      {
        "id": 121865,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Induction of labor at 37 weeks to reduce the risk of neonatal infection</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A pregnant woman is diagnosed with primary genital herpes infection. What is the most appropriate management regarding delivery?</span></span></span></p>",
    "unique_key": "Q4668838",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439084,
    "difficulty_level": "difficult",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Vaginal delivery if there are no active lesions at the time of labor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: If a woman has primary genital herpes before pregnancy or in early pregnancy and has no active lesions at the time of labor, vaginal delivery is usually safe. However, if she has active genital lesions or prodromal symptoms at the onset of labor, a cesarean delivery is recommended to prevent neonatal herpes infection<strong>.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If there is active genital herpes at term, cesarean section has to be done </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 673, High Risk Pregnancy: Management Options; David James, Philip J Steer; 5<sup>th</sup> edition</span></span></strong></span></span></p>",
    "correct_choice_id": 121863,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13334,
    "choices": [
      {
        "id": 53297,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Creatinine levels 1.24mg/dl</span></span></span></p>"
      },
      {
        "id": 53298,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Platelet counts 154000/microL</span></span></span></p>"
      },
      {
        "id": 53299,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alkaline phosphatase 142 IU/L</span></span></span></p>"
      },
      {
        "id": 53300,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Total protein of 252mg in a 24-hour urine collection</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A multiparous patient who did not attend any antenatal visit and came to causality with complaint of bleeding. On examination uterine tone was increased with BP&gt;144/92 mmHg. Which of the following tests supports the diagnosis of preeclampsia?</span></span></span></p>",
    "unique_key": "Q4501433",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439085,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Creatinine levels 1.24mg/dl</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Preeclampsia is&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">a pregnancy specific syndrome that can affect virtually every organ system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let&#39;s assess each option based on the above explanation:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Creatinine levels 1.24 mg/dl:</span></strong><span style=\"font-size:12.0pt\"> This is the correct answer. Elevated creatinine levels can be indicative of kidney dysfunction, which is one of the organ systems affected in preeclampsia. Kidney dysfunction can manifest as an increase in creatinine levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Platelet Counts 154,000:</span></strong><span style=\"font-size:12.0pt\"> Thrombocytopenia (a low platelet count) can occur in preeclampsia, but this value (154,000/microL) is within the normal range for platelet counts. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Alkaline Phosphatase 142 IU/L</span></strong><span style=\"font-size:12.0pt\">: Elevated alkaline phosphatase levels are not a specific marker for preeclampsia. Alkaline phosphatase levels can be affected by various conditions, including liver disorders, but they are not a primary diagnostic criterion for preeclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Total Protein of 252 mg in a 24-Hour Urine Collection</span></strong><span style=\"font-size:12.0pt\">: While increased proteinuria is a hallmark of preeclampsia, the total protein value of 252 mg in a 24-hour urine collection is is less than the cut off of 300 mg.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Preeclampsia Definitions</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\">Preeclampsia</span></em></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypertension and proteinuria&nbsp;<strong>or</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In absence of proteinuria, new-onset hypertension with the new onset of any of the following</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombocytopenia: Platelets &lt;100 x 10<sup>9</sup>/L</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Renal insufficiency: serum creatinine &gt;1.1 mg/dl or doubling of serum creatinine in the absence of other renal disease</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Impaired liver function: Elevated blood concentrations of liver transaminases to twice normal concentration</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary edema</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neuro: Unexplained new-onset headache unresponsive to medication (without an alternative diagnosis)&nbsp;<strong>or&nbsp;</strong>visual symptoms</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\">Preeclampsia with severe features</span></em></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Preeclampsia diagnosis, above, with any of the following</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe hypertension</span></span></span>\r\n\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">On two occasions at least 4 hours apart while on bed rest (unless already on antihypertensive therapy)</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombocytopenia: Platelets &lt;100 x 10<sup>9</sup>/L</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Impaired liver function (without an alternative diagnosis): Elevated liver transaminases greater than twice upper limit of normal&nbsp;<strong>or</strong>&nbsp;severe persistent right upper quadrant&nbsp;<strong>or</strong>&nbsp;epigastric pain not responsive to medications</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Progressive renal insufficiency: serum creatinine &gt;1.1 mg/dl or doubling of serum creatinine in the absence of other renal disease</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary edema</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neuro: Unexplained new-onset headache unresponsive to medication (without an alternative diagnosis)&nbsp;<strong>or&nbsp;</strong>visual symptoms</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note:&nbsp;</span></strong><span style=\"font-size:12.0pt\">The following are&nbsp;<em>not</em>&nbsp;diagnostic criteria for the diagnosis of preeclampsia or preeclampsia with severe features</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clinically evident edema</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rapid weight gain</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Massive proteinuria</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Does not qualify as a &lsquo;severe feature&rsquo;</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fetal growth restriction</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Expectant management &lsquo;may be reasonable&rsquo; if mother and fetus appear stable and no other clinical indication is present that would indicate the need for early delivery ACOG states that while it is important to monitor fetal status, FGR in the setting of all other fetal assessment being within normal limits (e.g., AFV, Doppler)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Uric acid</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyperuricemia in hypertensive pregnancy is not a diagnostic marker, but is an important finding as a risk factor for adverse maternal and fetal outcomes</span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Small for gestational age (SGA) infant</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prematurity</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Risk for adverse maternal outcomes if include patients with preeclampsia and risks increase with increasing concentration of uric acid</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">May be warranted in the setting of &lsquo;diagnostic dilemmas&rsquo; such as diagnosing superimposed preeclampsia in the setting of chronic hypertension</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>https://www.preeclampsia.org/frontend/assets/img/advocacy_resource/Gestational_Hypertension_and_Preeclampsia_ACOG_Practice_Bulletin,_Number_222_1605448006.pdf</strong></span></span></span></p>",
    "correct_choice_id": 53297,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13415,
    "choices": [
      {
        "id": 53621,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">6-10 weeks</span></span></span></span></p>"
      },
      {
        "id": 53622,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">12-20 weeks</span></span></span></span></p>"
      },
      {
        "id": 53623,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">24-28 weeks</span></span></span></span></p>"
      },
      {
        "id": 53624,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">36 &ndash; 40 weeks</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The highest risk of developing congenital varicella syndrome is? </span></span></span></p>",
    "unique_key": "Q8846765",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439086,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B. 12-20 weeks</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Congenital Varicella Syndrome is characterized by</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chorioretinitis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Microphthalmia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cerebral cortical atrophy</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fetal growth restriction</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydronephrosis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Limb hypoplasia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cicatricial skin lesions</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The highest risk of fetal infection is between 13-20 weeks.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 1212-1213, Williams Obstetrics 25<sup>th</sup> edition</span></span></strong></span></span></p>",
    "correct_choice_id": 53622,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13419,
    "choices": [
      {
        "id": 53637,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">CMV</span></span></span></span></p>"
      },
      {
        "id": 53638,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">HPV</span></span></span></span></p>"
      },
      {
        "id": 53639,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Rubella</span></span></span></span></p>"
      },
      {
        "id": 53640,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Tetanus</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">A 25 y woman is planning to conceive. She is unsure of her childhood vaccination status. Which of the following vaccines should she receive before conceiving? </span></span></span></span></p>",
    "unique_key": "Q7375443",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439087,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. C. Rubella</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pre-pregnancy, if rubella immunization status Is unknown, serological evaluation is done (IgG rubella) and if IgG Rubella is negative, then vaccination with rubella vaccine is recommended. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Very important! Conception is to be avoided for 1 month after vaccination with rubella as it is a live attenuated vaccine</span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 647, High Risk Pregnancy: Management Options; David James, Philip J Steer; 5<sup>th</sup> edition</span></span></strong></span></span></p>",
    "correct_choice_id": 53639,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13421,
    "choices": [
      {
        "id": 53645,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Consider termination of pregnancy</span></span></span></span></p>"
      },
      {
        "id": 53646,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Oral Acyclovir, antipyretics, and hydration</span></span></span></span></p>"
      },
      {
        "id": 53647,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">IV Acyclovir</span></span></span></span></p>"
      },
      {
        "id": 53648,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Varicella Zoster Immunoglobulin (VZIG)</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">A 24-year G2P1L1 teacher presents at 22 weeks with fever and rash since 2 days. She gives history of contact with a child in her class who had chicken pox 10 days earlier. What is the next best step in management? </span></span></span></span></p>",
    "unique_key": "Q9993027",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439088,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B. Oral Acyclovir, antipyretics, and hydration</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Chickenpox in Pregnancy </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">There are 2 important aspects to chicken pox in pregnancy:</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pregnant patient presents with rash (Chicken pox)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pregnant patient presents with contact with a person who has chicken pox, and is therefore at risk of developing chicken pox</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Scenario 1: Pregnant patient with rash i.e. she has already developed chicken pox</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Avoid contact with susceptible individuals, until the lesions have crusted over. This is usually about 5 days after the onset of the rash.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Symptomatic treatment and hygiene is advised to prevent secondary bacterial infection of the lesions.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Oral Acyclovir should be prescribed </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Intravenous Acyclovir should be given to all pregnant women with severe chickenpox. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">VZIG has no therapeutic benefit once chickenpox has developed</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Women who develop chickenpox in pregnancy should be referred to a fetal medicine specialist, at 16&ndash;20 weeks or 5 weeks after infection, for discussion and detailed ultrasound examination (Risk of congenital varicella)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">If maternal infection occurs in the last 4 weeks of a woman&rsquo;s pregnancy, there is a significant risk of varicella infection of the newborn. A planned delivery should normally be avoided for at least 7 days after the onset of the maternal rash to allow for the passive transfer of antibodies from mother to child. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Scenario 2: Pregnant patient with history of contact with a person who has chicken pox</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Determine if she has been vaccinated against chicken pox or has had the infection earlier (i.e. immunized)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">IF immunized, nothing further need be done</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">If not sure of status: Do IgG VZV</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">If IgG VZV is positive: she is immunized and nothing need be done</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">If she is IgG VZV negative or she is unimmunized: This means she is susceptible and should be given VZ IG within 10 days of contact. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\"><a href=\"https://www.rcog.org.uk/globalassets/documents/guidelines/gtg13.pdf\" style=\"color:blue; text-decoration:underline\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">https://www.rcog.org.uk/globalassets/documents/guidelines/gtg13.pdf</span></span></strong></a></span></span></span></p>",
    "correct_choice_id": 53646,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13427,
    "choices": [
      {
        "id": 53669,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Malaria</span></span></span></span></p>"
      },
      {
        "id": 53670,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Parvovirus </span></span></span></span></p>"
      },
      {
        "id": 53671,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Rubella</span></span></span></span></p>"
      },
      {
        "id": 53672,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Varicella</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Which of the following infections can cause fetal hydrops?</span></span></span></span></p>",
    "unique_key": "Q5142175",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439089,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B. Parvovirus</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Parvovirus B19 infects rapidly dividing cells</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It is cytotoxic for erythroid progenitor cells</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Parvovirus B19 infections in pregnancy can causes fetal anemia, hydrops and fetal death especially if infection happens within 20 weeks of pregnancy</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 654, High Risk Pregnancy: Management Options; David James, Philip J Steer; 5<sup>th</sup> edition</span></span></strong></span></span></p>",
    "correct_choice_id": 53670,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30493,
    "choices": [
      {
        "id": 121850,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reassure and advise symptomatic treatment</span></span></p>"
      },
      {
        "id": 121851,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prescribe antibiotics</span></span></p>"
      },
      {
        "id": 121852,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Order Zika virus testing</span></span></span></p>"
      },
      {
        "id": 121853,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Initiate antiviral therapy</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old pregnant woman in her first trimester presents with fever, rash, and</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> arthralgia. She recently returned from a trip to a region where Zika virus is endemic. What is the most appropriate next step?</span></span></p>",
    "unique_key": "Q7082989",
    "question_audio": null,
    "question_video": null,
    "map_id": 19439090,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Order Zika virus testing</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Given her symptoms and travel history, testing for Zika virus is crucial due to the risk of congenital Zika syndrome, which can cause microcephaly and other severe fetal brain defects. Testing is done by detecting Zika virus RNA by PCR in blood or urine. It is vector borne (mosquito).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zika virus in pregnancy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This RNA flavivirus is the first major mosquito-borne teratogen recognized </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zika virus is primarily transmitted by mosquito bite, but sexual transmission is possible.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Maternal-Fetal Infection: </span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zika infection is asymptomatic in approximately 80 percent of adults.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It may cause mild rash, fever, headache, arthralgia, and conjunctivitis lasting a few days. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The fetus can be severely infected whether the mother is symptomatic.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the most severely affected fetuses, a congenital Zika syndrome has been described that includes microcephaly, lissencephaly, ventriculomegaly, intracranial calcifications, ocular abnormalities, and congenital contractures</span></span></span><br />\r\n\t\t&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diagnosis and Management. </span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Laboratory testing for Zika infection is recommended in symptomatic gravidas with residence in or recent travel to areas with active dengue transmission and risk for Zika transmission </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serum IgM antibodies typically become detectable within the first 2 weeks and may persist for months. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For a pregnant woman within 12 weeks of symptom onset, PCR testing of serum and urine specimens for both dengue and Zika virus RNA is recommended. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For women with prenatal ultrasound findings suggesting congenital Zika syndrome, Zika virus PCR and IgM are initially performed on serum and urine. Amnionic fluid PCR may be performed, although less is known about its diagnostic accuracy for congenital infection.</span></span></span><br />\r\n\t\t&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;Currently, no specific treatment or vaccine is available for Zika infection, although several vaccines are in development </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Williams Textbook of Obstetrics 26<sup>th</sup> edition pg 3107</span></strong></span></span></p>",
    "correct_choice_id": 121852,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = '00095 Mid Day Module (Obg-1)';
        const quizFilename = '00095-mid-day-module-obg-1-15a5d3c2.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Mid Day Module"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>